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Abstrad
Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder cbaracterizcd by
congenital dysmorphic extremities, infantile onset obesity, progressive retinal
degeneration, renal aboormaIities, and male bypogonadism. lbere are atleasl fi\'e
genetic loci, four previously mapped (3p, Ilq, ISq and 16q), that give the same
pleiotropic BBS phenotype. The limited number ofcases aDd the genetic heterogeneity of
BBS have hindered efforts to positionally clone the BBS genes. Newfoundland, a genetic
isolale, is enriched for BBS with a prevalence (JlI7,SOO) that is ten times higher than the
world estimate. The availability of DNA from 17 of the 22 idenlified BBS families
provided an opponwtity 10 siudy the molecular genetics ofBBS in Newfoundland.
Seventeen families were genotype<! and linkage and haplotype analyses were conducted
at each of the four mapped loci (BOS!.BlJS.f). 1'l1Re families were assigned to the BOS!
locus. The finding of linkage disequilibrium resulted in the assignment of three
additional BOS! families and the refinement of the 80s! disease interva.l on chromosome
llq. One large family was linked 10 the relatively rare BSS3 locus and was used 10
confinn this locus and refine its map position on chromosome 3p. Six families were
excluded from aU previously mapped loci. A genomewide scan was used to successfully
map the fifth locus, BB$J. 10 chromosome 2q31. In summary, of the 22 Newfoundland
BBS families, six (27%) have been unambiguously assigoed to BOSl, one to 8OS3 (S%) -
and one to BBS5 (5%), suggesting that the relatively high prevalence ofBBS in
NewfoWld.land is the result ofa minimum of three BBS genes and a BBS! founder.
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1latroductio. aDd Overview
The Human Genome Project (HGP) is an inlemational research program designed
primarily to detcnninc the complete nucleotide sequen« of the human genome. By the
spring oflhc: year 2000,. first draft of the 3 billion base pair sequence wiU be released to.
Ute public domain (Franc:is Collins. Director ofNIH. in • public address to the 4~ annual
meeting of"The American Soc:ietyofHuman Genetics". San Francisco. USA). The
sequence will be accessible to anyone with a computer and a connection to the Internet.
However. annotation of the sequence, including the identity ofthe estimated -100,000
genes. representing a mere 100ft of the 3 billion bases. remains the most fonnidable task.
Of the -100,000 genes. only !O"/a or so are believed to cause disease phenotypes.
Mutations to the majority of genes are believed to cause either embryonic letba1s or.
conversely, subtle effects (modifier genes) or have no effect because of redundancy in the
genome. Comparative gcnomics holds great promise for the identification of not only
genes but entire biochemical pathways. Ho",,-evcr, to study the majority of human
diseases with a major genetic component, we must begin with the identity ofa human
gene because there are DO mown animaJ models or prior biochemical insighL In this
way, the annotation ofbwnan sequeDCes in public databases will continue to rely on the
exploitation of the most private of mutations. So. for the present generation of geneticists
on the brink ofthe "New Millennium". the rule still is "cherish your ex.ceptions".
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Bardet-Biedl syndrome (BBS) is a rare. recessive disorder with an estimated worldwide
prevalence of 1/125.()()()..I60,OOO. Mutations at any ODe ofat least five genes result in a .
relatively unified clinical presentation: congenital dystrophic extremities, infantile onset
obesity, progressive retinal dqeoeratioo. renal aboonnalities and male hypogonadism.
These major features of BBS arc: associated to varying degrees ,,-jth other features
including mental retardation and diabetes mellitus. The spectrum ofclinical
manifestations associated with the disniption of a single gene suggests that the putative
BBS genes are part of a unifying developmental network that continues to playa
functional role in the development and/or maintenance of adult retina, kidney, gonad and
adipose tissues. In this way, it is anticipated that the cloning oflhe 88S genes will
advance the study ofmore common diseases like obesity and diabetes.
As always, the studyofrare diseases is limited by the paucity of reponed cases and, in
the case of BBS, complicated by a growing list ofmappcd loci. Generally speaking., the
availability ofstudy patients can be improved and the genetic complexity reduced ifa
geneticaUy isolated population is identified with an increa.sed incldeoce ofdisease. nus
study was uDdertaku to advuee tile efforts D.dnway to .ap a.d eRe tile BBS
geDes. by the iDvestit;atiOll of palin.ls ucI tllrir fa.ilia affected by BSS i.
NewfouDdla.d, a leaetic811y isolated pofHIlatioa witll tn ti..a tile worldwide
pRYaleBee of DRS.
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1.2 Bardet·Biedl Syndrome
1.2.1 Nosology
In 1866, Laurence and Moon (and Hutchinson in 1882 ,1900) reported the features of
mental retardation, pigmentary retinopathy, hypogenitalism and spastic paraplegia in four
siblings of the same family (see OMIM 245800). A similar syndrome. charncterized by .
mental retardation, pigmentary retinopathy, and hypogenitalism, in the presence of
congenital obesity and polydactyly, was subsequently described by Bardet (1920) and
Biedl (1922) (see OMIM 209900). Since three of the four phenotypic features of
Laurence·Moon (LM; OMIM 245800) overlap with those ofBardet-Biedl syndrome
(BBS; OMIM 209900), Solis-Cohenand Weiss (1925) argued that LMand BBS were
variants of a single disease entity that should be referred to as the Laurence-Moon·Bied.1
(LMB) syndrome. Schachat and Mawnenee (1982) reviewed the nosography of these and
related. syndromes and argued. that BBS and LM are distinct. However, the issue is far
from settled. The LMB (or LMBBS) designation is readily found in the recent medical
literature and Beales et al. (1999) recently described the finding of neurological features
in patients meeting accepted. diagnostic criteria for BBS (Schachat and Maumenee 1982).
Until the genes are cloned, we cannot know which diagnostic scheme is genetically
relevant. For the purpose ofthis study, we considered BBS to be a distinct disease from
LM.
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1.2.2 Cardi••1Fatans .rBBS
Scbacbat and Mawnenee (1982) have suggested that the diagnostic criteria for DDS
shouJd include four of the five following major feal\ftS: meow retardation. obesity,
hypogenitalism. polydactyly and pigmentaJy retioopalhy. From extensive clinical
investigations ofDBS cases in Newfouodland.. we consider that mental retardation is not
usually present. if assessed ql.W'ltitatively, with tests that account for the visual defect in
these patients. Hypogeniwism is a consistent feature in men but difficult to assess in
women. Brachydactyly (short. broad hands and/or feet) and syndactyly (webbed fingers
and/or toes) are more frequent than polydactyly (extra flI1gers and/or toes) in patients
from Newfoundland. Renal changes, although not routinely assessed by others, are
prevalent and characteristic of BDS. Therefore, we have suggested that the cardinal
features of BDS are: obesity, male hypogenitalism., dystrophic extremities. retinal
dystrophy and renal disease. We considered the presence ofeither brachydactyly,
syndactyly or polydactyly in combination with retinal dystrophy and obesity (in the
absence of neurological compLiatious). to constitute the minimal diagnostic criteria
required to de6ne a BOS case (Harnett et aI. 1988; Green et aI. 1989; O'Dea et aI. 1996;
reviewed by Parfrey et aL 1997). The following gcneraI description of the phenotypic
features of aas is based on our observations in conjunction with other clinical reviews
(Bell. 1958; Klein and Ammann 1969; Scbachatand Mawnenee 1982; Riiseet aI. 1997;
Bealesetal.I999).
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Retinal Dystrophy
Severe rctina.l dystrophy is a consistent feahu'c and the most reliable diagnostic
criterion orOBS. Ancarly sign ortbe retinopathy associated with BOS is often the onset
of night blindness in children. After that. the visual loss is rapid (usually begins by seven
years) and involves central and/or peripheral vision loss that progresses to an
incapacitating blindness with a visual acuity at or below the ability to count fingers. The
retinal dystrophy in BOS patients was initially referTCd to as retinitis pipncntosa (RP).
RP is characterized by constriction of the visual fields. night blindness and fundus
changes, including dense bone.-spicule pigmentation.. pale optic d.iscs and attenuated
vessels. Most BBS patients are more likely to show sparse pigmentation with 01" without
va.sc::ular changes, mild to severe optic disk pallor and severely attenuated vessels. The
fundus appearance associated with BBS is different from isolated typical RP, the age of
onset is earlier, and the progression to blindness is more rapid in BBS patients than for
most RP patients. "Therefore. the retinal dystroph.y associated with BBS is referred to as
an "atypical" fonn of RP.
In Newfoundland, fifty percent of patients~ registCTCd as legally blind by 18 yean
of age with the age of registered blindness in patients ranging from 5 to 29 years of age.
Oph.thalmologk investigations of patients reveal markedly restricted visual fields, severe
abnormalities ofcolOl" vision, raised dark-adaptation thresholds and extinguished or
minimal rod and cone responses on e1cctroretillOgraph.y. Since the majority of patients
were a.sc::ertained through eye clinics. it is likely that the spectrum of eye disease in this
I";
patient group is biased towards BBS cases with severe eye manifestations.
Dystrophic Extremities
Postaxial polydactyly. involving from one to four extremities. is usually the first
clinical sign ofDBS and has traditionally been considered a cardinal feature of the
syndrome, However, polydactyly is not a universal finding: it is absent in at least 30% of
BBS patients, and, we bave found it to be less frequent than brachydactyly and
syndactyly. Since syndactyly in BDS palients may be subtle and brachydactyly is best
assessed with tt1elaCarpOpbalangeal pattern profile (MCPP) analysis, we suggest that any
one or combination of polydactyly, syndactyly and/or brachydactyly be referred to as
dysmorphic extremities and replace polydactyly as a cardinal feature of DDS.
Obesity
Obesity is a characteristic feature of BDS and, along with dystrophic extremities, useful
for the diagnosis of young children. Eighty-eight percent of patients from Newfoundland
were above the 90'" percentile of weight for height. The age of onset is typically between
2·3 years. The obesity associated with DDS is progressive with age but responsive 10
caloric restriction. The adipose tissue is diffuse in young children but predominantly
distributed to the trunk and the proximal seclions of the limbs ofadults.
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Renal Anomalies
Renal disease, although recognized frequently as associated with BBS, has not
traditionally been considered a cardinal feature of the disorder. Evaluation of renal
disease has suffered from problems of ascertainment bias and lack of appropriate renal
imaging studies. However, all patients identified through ophthalmology records in
Newfoundland had some abnotmality of renal structure, function or both. The
radiological appearance of calyceal clubbing, or blunting, non-communicating calyceal
cysts, or divenicula, and fetal lobulation suggest a defect in maturation of the kidneys.
Renal impainnent (as defined by a creatinine clearance of less than 1.2 mUsec or a serum
creatinine >120 ",molL) was detected as early as 2 years and occurred in 25% ofBBS
patients examined. By age 48, 25% ofBardet·Biedl cases bad chronic renal insufficiency
(Harnett et a1. 1988; O'Dea et aI. 1996). The consistency of renal findings among BBS
patients from Newfoundland (unselected for kidney disease), and elsewhere (if imaging
tests are done), suggest it is a cardinal feature of BBS. Renal imaging to test for the
persistence of fetal lobulation (ultrasound) and calyceal morphology (intravenous
pyelography) should be perfonned on suspected BBS cases. The significance of the renal
findings are underscored by the fact that renal impainnent is an important cause of
morbidity and mortality in BDS patients.
Male Hypogenitalism
Although adults with BBS have secondary sexual characteristics, male hypogenitalism
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is ocarly always present. aDd presents as smalilestes aDd a very small penis. A valuable
diagnostic criterion in males, poor sexual development is difficult to assess in females.
The majority of women with DDS report inegular menstruation and relative infertility and
recent repons emphasize the imponaDce ofexamination ofyoung female patients in light"
of the findings of vaginal atresia and bydrometrocolpos in females (David et al. 1999;
Oguzkurt et al. 1999). However, there are reports of women with DBS who have given
birth to children, including two patients from Newfoundland.
1.2.3 Minor Features of BSS
Other clinical manifestations associated with DDS include mental retardation,
hypertension and diabetes mellitus (usually non-insulin dependent). As well, patients
often present with other ocular findings associated with retinaJ. dystrophies, such as
myopia., astigmatism, nystagmus, glaucoma, and cataracts. Failme to meet developmental
milestones and behavioral affects such as inappropriate mannerisms and emotional
immarurity are frequently reported in DBS patients. Since some of these traits may be
confused with mental rewdation, there should be formal testing for mental capacity that
takes into account the visual deficit.
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1.2.4 Cliaical Heteropllrity orBBS
Pleiotropic genes. or genes that affect a wide array of tissues and organs, frequently
show variable severity of the phenotype (expressjvity). This is cetta.in.ly the case with
BBS, in which the number and severity ofmajot'" and minor manifestations ofBBS are
quite variable, e~ among patients within a family (reviewed in Q_pcer 3). A
particularly illusuative example ofme complex nature of the BBS pbeootype was
recently reponed in monozygotic lwins: one twin was born with polydactyly oftlu-ee
limbs while the other had no polydactyly (Beales et aI. 1999). This variability, along with
the delay in onset of age-dependent features, may make it difficult to make an accurate
andlor timely diagnosis because of Ute inability to exclude syndromes with overlapping
phenotypes (table 1.1), particularly in yOWlg patients (Beales et aI. 1999). Several other
syndromes ofunknown etiology, beside LM, have overlapping features with BBS.
Notable among these are Biemond syndrome n (OMIM 210350) aod Alstrom syndrome
(OMIM 203800) that can be distinguished from BBS by the presence of iris coloboma
and deafness.. respectively (table 1.1). David et aI. (1999) recently reponed nine BBS
patients who 'Were mis-diagnosed in infancy with McKusick-Kaufinan syndrome (MKKS;
a recessive condition characterized by postaxial polydactyly, vaginal atresia with
hydrometroeolpos and congenitaJ hean defect; OMIM 236700). This may indicate a
general undereporting of the incidence of BBS.
An early, accurate diagnosis of BBS is very important for disease management in
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patients. The provision of special education with low-vision aids, dietary intervention to
prevent or treat obesity and diabetes mellitus, treatment of hypertension and chronic renaJ
failure, and counseling around issues ofcontraception, genetic risk. and end-stage renaJ
therapy options, can do much to improve the quality of life for these individuals and their
families.
Table 1.1
Differential Diagnosis of 888 a.d SyudrollleS witll Over"ppiag PlintOtypn
Cardinal Feanues ofBBS BBS LM Biemondll Alstrom
Renal abnormalities .,-
Dysmorphic Extremities .,- .,-
Retinal dystrophy .,- .,- .,-
Obesity .,- .,- .,-
Male Hypogenitalism .,- .,- .,-
Features ofOverlapping Syndromes BBS LM Biemond U Aistrom
Mental Retardation .,- .,- .,-
Diabetes mellitus .,- .,-
Spastic Paraplegia .,-
Iris Coloboma .,-
Deafness .,-
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i.l.S Gftletic Hderoparity .rBBS
aas is clearly an autosomal n:cessive disorder. At the:start ofmis study, four distinct
genetic loci (8BS/, IlqlJ; 8SS1. 16q21; 8BSJ, Jpl3-14; 88$4, ISq21-2J) had been
mapped and a fifth locus was anticipated due to the frequent ftnding of unlinked families
(reviewed in Ch.pter 2). In conuast to genetically homogeneous disorders, the genetic
heterogeneous nature ofBBS makes it difficult to assign a single family to any given
locus. Although problematic for genetic analysis., the underlying genetic heterogeneity of
BBS raises the possibility that locus-specific phenotypes account for the variable
expressivity of the disorder. Th.i.s hypothesis has received little attention because most
BSS families cannot be competently assigned to a specific BBS locus. A cursory
exploration oflhis is made in Claapter 3. in which the phenotypes of affected memben in
two BBSJ-linked families, are examined fOl" BBSJ-specific patterns ofexpression. It is
not expected that all of the pbeoocypic variation will be explained by Locus-specific
expression, bec:ause it cannot KCOWll for the widely observed intrafamilial variation
(reviewed in Ch.pter 3). Even though BBS is a "single geDC~ disorder, other factors,
such as other genes (modifiers), environmenlal cues, stochastic influences, etc., obviously
modulate the phenotype. The study oflhe complex determinants of"pbenotype" is a
growing branch of genetics (phenomics) and will be relevant to the investigation of BBS
once the genes are identified.
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1.3 Geae Discovery
1.3.1 latTodllCtioa
Over the past 20 years. the era of"geDeti<: engineering" has resulted in the ability to
clone and sequence genes. Initially, the only genetic diseases that \o\l:fe amenable to
analysis at the gene level were those in which prior information about the biochemical
defect was known. Disease genes that were identified from prior functional knowledge
include the genes for beta-thalassemia (Orlrin et at. 1979) and phenylketonuria (Dilella el
at. 1986). This functional approach to gene mapping was fruitful but restrictive; the
majority of the more than 10,000 genetic diseases cataloged in McKusick's "Mendelian
Inheritance in Man" Cbnp:l/www gcbj Dim gQy/gmjml give DO clues as to the biochemical
nature of the causative: genes.
A major advance in gene discovery was the strategy of positional cloning, a systematic
approach to the identification ofdisease genes without func:tiooal information_ The
discovery ofgenetic markers (Bolstein ct at. 1980). advances in cloning and sequenc:in&
techniques (Bwte et al. 1987), and the application of pre-existing theories and algorithmS
for linkage analysis (Elston and Stewart 1971; Ott 1974), allowed the identification of
markers in the genome that cosearegate with disease in families. The chromosomal
position of markers linked to disease loci predict the position of the disease gene (Collins
1991). The first step in positional cloning is linkage analysis to map the gene oCinterest
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to a particular chromosomal n:gion. The ultimate goal is the identification of a disease-
causing gene in lite region. So far, mon: than 100 genes have been identified by
positional cloning (http://genome.nhgri.nih.gov).
1.3.2 Marken and Maps
Most genetic diseases are caused by variations in DNA sequence. However, the vast
majority of variation observed in lite human genome is not deleterious. These innocuous
sequence variations, or polymorphisms, can be detected at the DNA level and used as
markers for finding disease genes. The most pn:valent type of polymorphic sequences in
lite human genome are variations that occur at random in the genome to single
nuc1eotides (single nucleotide polymorphisms; SNPs) at approximately one in every 100-
300 base pairs (www.ncbj nlm nib gov/soP/index hbDl). Also abundant in the genome
are nllcrosalellites, consisting of repeats of simple sequence embedded in DNA wilit
unique sequence. The variation is in the length of the sequence which, in tum, depends
on the number of repeated units (e.g.• di- ,tri·, and tetra-nucleotide repeats) (Beckmann
and Weber, 1992; Heame etal. 1992). The most useful markers for linkage analysis are
highly polymorphic (multiple alleles of near equal frequencies) and located at known
positions with respect to other genes and markers on specific chromosomes.
1.3.3 Linkage and Haplotype (Rec:o.bblatiOll) A.-lysis
The primary goal of linkage analysis is to determine if two or more genetic loci (e.g., a
marker and a disease locus) are oosegrcgating in a pedigree. The principles of linkage
analysis are based on the behavior of chromosomes in gametogenesis. During meiosis,
homologous chromosomes pair up and then separate into different gametes. During this
process, sister chromatids may break and recombine by a process known as crossing over,
resulting in the exchange ofgenetic material (recombination). Mendel's law of
independent assonrnent slates that iftwo loci are located on different chromosomes, they
will segregate indepeDdently ofeach other 500.!o of the time. However, due to
recombination, the frequency ofcosegregation of two loci on the same chromosome is
usually less than 100%. The number of recombinants per meiosis (theta., 9) is dependent
on the degree of physical separation between two loci (the value ofa equals the portion of
offspring that are recombinant). As crossovers occur more or less randomly along the
chromosome, they rarely occur between loci which are physically close together.
Linkage analysis is a statistical assessment of the likelihood that genetic loci (e.g., a
marker and a disease locus) are inherited nonindependently from each other within
families. The LOD score, Z, introduced by Monon (1955), is the logarithm of the odds
that the loci are linked (9< OS) rather than unlinked (9- OS). LOD scores are calculated
by looking at each meiosis in tum and comparing the likelihood of the observed
genotypes on the alternative hypothesis of linkage or no linkage (9= 0.5). LOD scores are
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calculated for a range of9 values in order to estimate the maximum Z score. The power
ofthe analysis can be intte.ased by using multiple pedigrees and summing the LOD KOfeS
across families. A LOO of3 or more indicates a 1000;1 odds that the loci are linked
versus not linked (for a given value of9). A LOO score of·2 is taken as strong evidence
that the loci are not closely li.nked. Two loci whicb show 1% m;:ombination are defined
as being 1 ceotimorgan (cM) apart on a genetic map. A genetic distance of I eM, on
average, represents approximalely I megabase (Mb) of DNA sequence.
Linkage is confirmed by typina other markers in the vicinity of the linked marker
and/or by typing additional families. The aUeles that are transmitted from parent 10 child
are arranged in linear order (haplotype), corresponding to the map position of the
markers. A haplotype that is transmitted, unahen::d, from parent to child is said to be
nonrecombinant (parental). ldentifying markers that have recombined with the disease
trait an:: used to define the minimal region that must contain the disease gene (referred to
as the disease interval ~ critical region).
1bere are special cin;:umstaDceS., both at the population and subpopulation level, where
matings between related individuals are frequent Consanguineous unions may be
tolerated, or even encouraged, as a resultofculturaJ tradition (e.g., among the Bedouin)
(Sheffield et aI. 1998). Ahernatively, individuals may be relaled through a common
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ancestor due to geoetic isolation as a result ofbistoric;al. geographical, OI'culturai
isolation. lbe relatively small number of founders that are characteristic oftbcse
populations facilitate the.sean::h for human disease genes. 'There are various populations .
like this around the world. one ofme most well known being the Finnish population
(reviewed by de la ChapeUe 1993). Rare genetic diseases that occur in founder
populations are more likely to be caused by homozygosity of a single founder mutation
than by two independent rare events (different mutations). More to the point. marken
tightly linked to the disease gene that have nol recombined can be identified in affected
individuals as homozygous alleles. Individuals with a rare genetic disease from a founder
population can essentially be considered as members ofone very large kindred. without
knowing bow they are related. This allows refmement ofme disease inlerval by linkage'
disequilibriwn (LD) mapping to Klentify historical recombinations of the fowxkr
haplotype. Homozygosity mapping in consanguincoos kindmls and LD mapping in
founder populations are powerful methods for both locating and fine mapping of disease
.-.
The population of Newfoundland bas features that make homozygosity and linkage
disequilibriwn mapping feasible. 1be colonization of the island occurred primarily by a
natural increase from northern EW'Opean senlers of English and Irish extraction who
participated in the mercantile fishing industry in the 1700 and 1800s. Mating segregation
between Irish Catholics and English Protestants, low immigration, and geographical
isolation of fishing communities have resulted in genetic isolation of the population.
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1.3.5 Positiollal CIoaia.ef DiseaH Gaa
Define the DiseaR ancI Col/ect Fomilies
A general. strategy for positional cloning ofa single gene trait is diagramed in 6g. 1.1.
The first priority (step I) is to carefully define the phenotype of the disease. Strict criteria
will limit the cases available for study but a broad dcfmition may result in the inclusion of
cases that are genetically heterogeneous. For instance, in this 5lUdy, LM patients were
excluded in case LM is a distinct entity encoded by non-BBS genes. Once the pedigrees
are obtained (step 2),lhe genetic model or mode of inheritance (step 3) must be
determined, including the penetrance (the probability that a genotype will yield the
predicted phenotype). Until the BBS genes are cloned, the frequency of unaffected gene
carrier.> can only be estimated. Peoctranee values between 0.9 and 1.0 are routinely
employed in linkage studies ofBBS based on the consistency oflimb dysmorpbology,
retinal dystrophy and obesity in affected child and adult members of BBS families and the
fact that the observed frequency ofaffected offspring in families of BBS cases
approaches that expected ofan autosomal recessive disease that is fully penetrant. Steps
1-3 were completed prior to the present study(Hamett et aI. 1988; Green et aI. 1989;
O'Deaetai. t996).
Genotype Families and Analyze Dato
Blood samples are collected for DNA extraction from patients and available first and
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Figure 1.1 Step~wise approach to positional cloning (adapled from "Protocols in
Human Genetics")
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second degree relatives (step 4). Ifc:andidaIc loci are to be tested, polymorphic marlcers
within lite disease interval of each candi<IaJe locus will be genotyped. If00 candidate loci
for the disease are known. the markers selected will consist of a panel of-200-300 evenly
spaced, highly polymorphic markers for a gcnomewide scan (stcp 5). Linkage analysis is
performed under the genetic model oftbc disease (step 6). LOO scores > 3 constitute an
initiallocalizatioo (step 7). Additiooal markers aodfor families are geootypcd to coofum
the linkage. Haplotypes are ~oded by typing additional markers in the vicinity oftbc
linked marker and all informative crossovers involving disease haplotypcs need to be
identified (step 8) as this will dctenninc the amount ofeffort it takes to find the disease
gene. Homozygosity and LO mapping. ifapplicable. are employed. The flow of eveots
depicted in fig. 1.1 is two-way and any nwnbcr of loops can be created. For example. the
n:cruitment of patieots and family members is often an on-going process. As well, once
the critical region has been refined, it is prudent to look for candidate genes before
proceeding wilh physical mapping.
Identify the Disease Gene
Identifying the disease gene (step 10) involves finding functiooal mutations in a geoc
that coscgregate with disease in affected families. A necessary but loathsome junclW"e
between refinement of the genetic interval and gene identification is physical mapping
(step 9). The goal of physical mapping is to identifY all genes within the disease inlervaL
This involves obtaining sequence data within the genetic boundaries of the disease and
identifying aU gene sequences. Genes may be recognized by their sequence: signatures,
like CpG islands., conserved sequmccs, open reading frames, or by scan::hing for
expressed sequence tagged sites (ESTs) that map to the rcsion. or by comparison with
syntcnic regions in the mouse. A physical map consists ofcloned DNA fragments
assembled into overlappina: contiguous segments (contigs) constructed across the reston.
The amount oftime and effon required to identify thedi.sease gene wiU depend DOt only
on the physical distance bctwecD boundary markers (thus the importance of step 8), but
also on the complexity ofthc sequence. A high intrinsic gene density (e.g., Ilq13) or the
presence of reiterated sequences (e.a:., pseudogenes within the disease interval oftbe
PKDl gene (The International Polycystic Kidney Disease Consortium, 1995», may
complicate efforts to identifY the disease gene. A -I-Mb critical region is usually
considered small enough to start the physical mapping stage.
As a direct benefit from the: rapid progress ofthe HGP, the DCCessity for every lab 10
develop a physical map oftheir "region of interest'" is diminishing as ItlOfe of the hWJWI
genome is sequenced. At the moment, the completeness of the genetic and phystcaJ map
and the amount of sequencina: data vary lICI'OS5 the genome. The complete sequeoce of
chromosome 22 is publlshed (Dunham et aI. 1999) but there is a notable lack of
sequencing information available for chromosomes 2 or 3 (www.ncbLnlm.nih.gov).
Soon, it should be possible to tap into the various genomic databases and pick out
candidate genes without having to do any physical mapping.
Once the disease gene is identified, there are several possible scenarios that will dictale
the rate of progress in elucidating the: pathophysiological processes of the disorder. !fthe
sequence represents a novel gene, i.e., lhere is no available information about its function
(e.g., ORCA 1 and OReA2; reviewed by Wdcsh et at. 1998), then there is much work to
be done. However, if the disease gene shares some coding sequence with other known
genes, (e.g., a protein motif with known function), gene function may be predicted as was
the case in the identification oftransmembrane domains in the gene for cystic fibrosis
(see OMIM 602421). The best case scenario is that the gene is bomologous to other
genes or class ofgenes that are well represented in other model organisms, such as the
nematode, fly or mouse. Information obtained from a positive "hit" in a model organism
may instantaneously identify not only the disease gene, but its location in the cell. its
function, biochemical pathway and evolutionary history and provide animal models for
study (e.g., MSH2 gene; see OMIM 120435). The nwnber of positive "hits" should
increase exponentially as data accumulates in the public databases. Once the disease gene
is identified, the type and scope of studies available are limitless and often begin with the
identification or making of a transgenic animal disease model.
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1.4 OutUDe of IDvestic_tioa
Within this thesis. the results ofa genetic survey ofDBS families originating from
NewfolIDdland are discussed. At the onset oftbis projcct, four DDS loci (BBSI-BBSf)
had been mapped but the assignment oftbc BSSJ locus (3pll-pI2) was still provisioaal.
Recent surveys reportN thai the majority offamiHes with DDS were linkN to the BSSI
locus on chromosome Ilqll and predicled the existence ofa fifth BBS gene in the
genome.
Linkage and haplotype analyses were perfonned. on 17 Newfoundland families affected
with DDS at the four known loci (CII.pter Z). The finding of linkage ofone el(lended
family from the Conception Bay area to the rare BSSJ locus confumed the original
linkage report and provided the opportunity to examine the BSS) phenotype.
lntrafamilial recombination analysis was used to refine the location oftbe BSS) gene
(Chapter 3). An unlinked. consanguineous family from \\'bite Bay (Cbpter 1) was
infonnative enough to use in a successful genomewidc: search for a new BBS locus
(Chapter 4). lbe finding of several families from the south and southwest coast of the .
island with evide~of linkage to BSSI (Chapter 1) prompted a search foc an underlying
founder effect (Cllapte-r 5). The impact oftbese studies on the direction offulW'e DDS
research, with emphasis on the most feasible approach to done the first BDS gene, is
discussed (Chapter 6).
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Summary
Bardet-Biedl syndrome (BBS; OMIM 209900) is a rare, autosomal recessive disease:
cbaracterized by dysmorphic extremities, obesity, retinal dystrophy, bypogenitalism in
males and renal strueturaJ abnormalities. So far, four distinct BBS loci (BBS/:llq;
BBS2:16q; BBSJ:3p; BBS4:1Sq) ha\'e been mapped. The island popuJation of
Newfoundland, considered a geoetic isolate due to the nature of its founding and
subsequent isolation. is enriched for BBS with ten times the prevalence ofother
Caucasian populations of northern European ancestry. A population-based genetic survey
was performed on 17 Newfoundland BBS families. Twelve multiplex and five singleton
families containing 36 affected individuals were tested for linkage at eacb of the four
kno\\-n BBS loci. Ofthc 17 families, ten were informative for linkage and could be
unambiguously assigned. Ofthcse, three families (30%) were linked to BBSI and one
family (10%) was linked to BBSJ. Most notably. six of the informative families (60%)
.....-ere excluded fiom alllcno....-n BBS loci. These results suggest that the high prevalence
oraBS in the Newfoundland population is due to multiple BaS genes and that a
significant portion of families are linked to one or more novel BaS loci.
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lntroductioD
Bardet-BiedJ syndrome is cbaracterized by reti.na.I dystrophy, obesity, dystrophic
extremities., and bypoptalism in males (Schacbar. and Maumenee 1982; Green et aI.
1989; Pacfrey et aI. 1991). Structural anomalies of the kidneys., such as persislent fetal
lobulation and calyceal abnocmalities are also characteristic ofNeoMoundland BBS
patients, with renal impainnent being a frequent and important cause of death (Harne« et
aI. 1988; O'Dea et aI. 1996). Four BBS loci, each on a different chromosome, have been
identified: BBSI on chromosome Ilq (Leppen et aI. 1994); BSS2 on chromosome 16q
(Kwitek-Black et aI. 1993); BSSJ on chromosome 3p (Sheffield et aI. 1994) and 8BS" oli
chromosome 1Sq (Carmi et aI. 1995). There is also evidence for a fifth locus in recent
reports of families that are excluded at all four BBS loci (Beales et aI. 1997; Bruford et aI.
1997).
BBS is a relatively rare disorder with a prevalence ranging from 1/160,000 in
Switzerland (Klein and Amman 1969) to 1/125,000 in the United Kingdom (Beales et aI.
1991). E....en though the island ofNewfoundland was settJed predominantly by nonhero
Europeans, the prevaleocc: ofBBS is teD times higher than these estimates (1117,500;
Green et aI. 1989) and more closely resembles that found among the Bedouin of Kuwait
(1/13,500) where consanguinity is frequent (Fanlg and Teebi 1989). In order to
investigate the high prevalence orBBS in the Newfoundland population and, in
particular, to delennine ifit is the result ofa single founder effect, we genotype<!
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members of 17 families affected with BBS wing polymorphic microsatellite markers
spanning the critical regions of each ofme four known BBS loci.
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Materials and Metbods
Subjects
Twenty.two families with BBS have been identified from the island of Newfoundland
(Green et aI. 1989; Hamettet aI. 1988; O'Deaet aI. 1996). Of these, 17 families were
available for genotyping (fig. 2.1). These families are widely distributed in coastal
communities around the island (fig. 2.2). Consanguinity between the parents of affected
individuals was documented in five families (B3, B8, B9, Bl3, and 814), and suspected
in seven families (B2, 810, Bll, BI2, 815, 816, and 819) based on progenitors with the
same surname and originating from lhe same community (fig. 2.1). "The natural history of
the disease in patients originating from the island has been previously reported (O'Dea et
al. 1996; Parfrey et al. 1997).
Clinical Investigations
A protocol for clinical investigations was approved by the Human Investigations
Committee of the Faculty of Medicine, Memorial University ofNewfowulJand, and by
the Medical Advisory Council of the Health Care Corporation orSt. John's. Diagnosis of
affected family members was based on the following criteria: the presence of retinal
dystrophy, obesity and dysmorphic extremities, in the absence of neurological
complications.
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Figure :U Pedigrees of 17 Newfoundland BSS families. Filled symbols indicate
individuals diagnosed with Bardet-Biedl syndrome (BBS). Double marriage lines depict'
consanguineous unions: documented (solid line) and suspected (dashed line).
Figure 2.2 Geographical distribution oflbe L7 Newfoundland BBS families available
for genotyping.
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Genotyping
Blood was collected from 20 males and 14 females diagnosed with BoS and III
unaffected family members. DNA was prepared from whole blood using a simple salting
out method (Miller et al. 1988). PeR using 100-200 ng of template DNA was conducted'
with primers purchased from Research Genetics [nc. (Huntsville, Alabama, USA). One
primer of eacb pair was end-labeled using T. polynucleotide kinase (phannacia Biotech,
Uppsala, Sweden) and y_J2p AIP (Amersham, Ontario, Canada). Samples were subjected
to 27-33 cycles of 94°C for 30 sec (denaturation), 55-65°C for 20 sec (annealing) and
7ZOC for)O sec (elongation) after an initial denaturing step of2 min at 95°C. Amplified
DNA was run on urealpolyacrylamide denaturing gels with or without formamide (Litt et
aI. 1993). Autorads were developed after 2-5 days exposure and the alleles were scored
blind with respect to disease status.
Linkage and Haplotype Analyses
Two-point linkage analyses were performed using the MLINK subroutine of
FASTLINK (V4.0P) (Lathrop and Lalouei 1984; Cottingham et al. 1993; Schiffer et aI.
1994). LOD scores were calculated for the most infonnative microsatellite markers
spanning the critical region of the fOUl BBS loci, for each pedigree. Infonnative markers
were recognized as those in which the parents were heterozygous for distinct genotypes.
BBS was modeled as an autosomal recessive disorder with a penetranee of I. The disease
allele frequency was adjusted to 0.008, based on the disease incidence of 1/17,500 in the
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Newfoundland popuJation (Green et 81. 1989). Haplotypes, representing the minimal
number of recombination events, were constructed manually from a minimum of four
markers spanning each of the four BDS critical regions (fig. 2.3) for all families.
Locus AssignmenllExclusion Criteria
Several criteria were used to assign or exclude a locus based on informative haplotypes
within families. A locus was excluded on the basis ofeither, (i) shared haplotypes
between affected and unaffected siblings, andfor (ti) the presence of dissimilar haplotype!
among two or more affected siblings. These resuJts were supported by significantly
negative LOD scores (s -2.00, 9=0) for infonnative markers. Support for linkage 10 a
locus was given in consanguineous families if the affected individuaI(s) displayed
homozygosity by descent (HBD) in the critical region of only one ofthe four BBS loci
and their unaffected siblings did not (Lander and Botstein 1987). In families where there
was unconftrmed or no indication of consanguinity, either homozygosity by state (HBS)
or haplotype sharing (HS) of the BBS crilical region in affected but not unaffected
sibling(s) and positive LOD scores were interpreted as support for linkage.
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Figure 2.3 Relative map position of the polymorphic markers used to genotype the
families at each. of the four mapped BBS loci. Boundary markers for each BBS interval
(Kwitek-Black et aI. 1993; Leppert et al. 1994; Sheffield et aI. 1994; Carmi et aI. 1995)
are denoted by •. The marker D3S1254 was replaced by the more polymorphic marker
D3SJ 776, located < 1 cM away. Genetic distances are based on the Genethon and
Marsfield sex-averaged linkage maps (Genome Database). Not all markers were typed or
were informative in all families.
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Results
Families Assigned to DDS I
Ten of the 17 DBS families were particularly informative and could either be assigned
to a single locus or excluded from aU four DBS loci. Ofthese, three families (88, BIO,
and B19) were assigned to BBS/ (table 2.1). The affected sib in family D8, the child of a
second cousin union, was HBD for the entire BBS! critical region. The affected sib was
not HBD at the BBS2, BSS3 or BBS410cus (fig. 2.4). Fwthermore, family B8 was
excluded from linkage at BBS2 and BSS3 on the basis of haplotype sharing between
affected and unaffecled sibs. Even though the BBS4 locus could not be excluded, family
B8 was assigned 10 BBS! on the basis of homozygosity mapping in a known
consanguineous family.
Family B19 was assigned to BDS/ on the basis of homozygosity mapping ina
suspected consanguineous family, even though the BBS2 and BBS4 loci could not be
excluded. The affected individual in family Bl9 is the offspring ofa suspected
consanguineous union and the only family member homozygous for all markers typed
within the ens/ critical region. The affecled child was nOI homozygous for the BBS2,
BDS] or BBS4 disease intervals (fig. 2.4). The DBS) locus could be excluded on the basis
of shared haplotypes between the affected and unaffected sibs.
Family BlD was assigned to BBS/ 00 the basis ofHS between the two affected
individuals. Persons 9 and 22 shale baplotypeS exclusively at the BBSI locus (fig. 2.5).
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figure :2.4 Core pedigru:s offamilies B8 and BI9, two of three families assigned
to the BSS/locus. Haplorypes are sbo,,-n for each oftbc four BBS loci aDd represent
the minimwn number of recomblnations. Dotted lines denote suspected
consanguinity; brackets indicate infened haplotype5; an R denotes a recombinant.
c-::r:-:r-r-[:,rn,:,:":~:,'.J,,..; :-:,. , ::;',.:~:,:.--,---,::~nH :rt-;; ntt.
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Figure 2.5 Core pedigree offamily 810 assigned to the BBSJ locus. Brackets
indicate inferred haplOl)'pCS; an R denotes a recombinant. Haplotypes lIR shown for
each of the four BSS lod and represent the minimum nwnber of recombinatioDS.
Doned lines denote suspected consanguinity; brackets indicate infem.d haplotypcs; an
R denotes a recombinant.
Both exclusion criteria \\-'ere met at each oftbe other thn:e loci in which the affected
siblings inherited dissimilar haplotypes with each other but shared haplotypes with
their unaffected siblings at BSS1, B&S3 and BBS4 (fil. 2.5). Markers mapping 10 the
BSSI region gave positive laD scores (e.g.• WD of 1.60 at e-o for marker
DIIS4095) and those at other loci yielded significantly negative LOD scores (table
2.1).
Family Assigned 10 BBS3
Family 82 is a large. multiplex family with five affected individuals in two
sibships. The parenes of both sibships are believed to be consanguineous. All
affected individuals in this kindred were: homozygous for at least foW'ofthe five
markers typed at the BBSJ locus (fig. 2.6). Funhennore, it was appamlt that all
affected individuals were homozygous for a single. disease-associated BBSJ
haplotype from a recent common ancestor (fig. 2.6). Linkage and haplotype analyses
support the exclusion of family B2 at BBSI, BSS]. and BSS4. Therefore, family B2
was assigned to BSSJ on the basis ofbomozygosity mapping in a suspected
consanguineous family.
Exclusion ofFamilies from All Known BSS Loci
Remarkably, six of the ten infonnative families (83. 84, 85. 86. 89. and BI3)
were excluded from linkage at all four BDS loci. suggesting the presence ofat least a
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Figure 2.6 Core pedigree offamily B2 assigned to the BBSJ locus. HaplotypcS
represent the minimum number of recombinations. Doned lines denote suspected
consanguinity.

fifth BBS locus in the human genome (table 2.1, fig. 2.7; Appendices 2, 3, 4, 5 and 9).
The affected individuals in three of these five Idndreds (B3, 89, aDd 813) are the product
of consanguineous unions.. Oftbese unlinked families, family B9 is remarlcable in that
five BBS patients are distributed among three sibships interR1atcd by three inbreeding
and two marriage loops (fig. 2.7). This informative family ~'llS used to search for a fifth
BBS locus employing lhe technique ofbomozygosity mapping (Lander and 80tstein
1987) (Ch.pter 4).
Unassigned (Uninformative) Families
It was not possible to assign seven families (BI, B7, BII, 812, BI4, 815, and 816)
with confidence to a particular locus or to exclude them from all known BBS loci (table
2.1; Appendices 1,6, 7,8,10,11 and 12). This usually was tbe result of poor ped.igree
structure. For instance, the abseocc: of unaffected individuals in affected sibships is
particularly uninfonnative because one of the two exclusion criteria (i.e., shared
haplotypeS between affected and wWfected siblings) cannot be applied (e.a.. families BI,
BII, and 816). For example, the two affected individuals in family BII share the same
haplotype within the critical regions oftbe BSS2, BBSJ and BBS4loci. giving equivocal
evidence for linkage at three BBS loci (table 2.1; Appendix 7).
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Discussion
A genetic survey was conducted on 17 of22 families affected with BBS in the
Newfoundland population. Ten of these 17 families were particularly infonnative and it
was possible to either assign or exclude them at each oCthe four known BBS loci. Four
ofthe families were linked to known BBS loci and six were unlinked at all four BBS loci.
At the conclusion of the present study, twelve ofthe 22 BBS families identified in
Newfoundland (five unavailable families and seven uninfonnative families) remain
unassigned.
The most striking outcome of this study, in comparison to two similar studies of
predominantly northern European families, was that the majority of infonnative
Newfoundland families (60%) were unlinked at all four known BBS loci. Although this
is not the first repon of unlinked BBS families, the relative proportion among families is
high. Beales et aI. (1997), in a survey of 18 families, found that 28% of fami.lies were
unlinked and Burford et aI. (1991) reponed an even smaller portion (8%) of unlinked
families in a larger study of29 families. The finding of unlinked families in previous
reports and the overwhelming evidence from this study suggest the existence ofat least a
fifth BBS locus.
Three ofllie ten infonnative families (300/0) were linked to the BBSJ locus. The
predominance of RBSJ families among linked kindreds ofoortbem European ancestry has
been previously reported. Surveys of 47 BBS families (of predominantly northern
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European descent) have found that 36-;0--56% offamilies are linked to BBS! (Beales et aI.
1997; Bwford et aI. 1997). If the three uninfonnative families that could not be excluded
from BBS! (table 2.1) are. in fact, BBS! families. the maximum. potential contribution
(based on 17 families) ofme BBS! locus in the Newfoundland population is 35%. These
results suggest that the burden ofBBS! in the Newfoundland popuJation (300/0-35%) may
reflect that reported in other northern European populations (Beales et aI. 1997; Bwford
etaL (997).
Although nooe of the families in this survey were assigned to either BBS2 or BBS4.
these loci cannot be considered absent from the popuJation because of the remaining
unassigned families. Of the seven uninformative families. six families (B I. 87, 8 II,
B12. B14. and B15) could not be excluded fromBBS2 and four families(BI, Bll, BI2,
and B15) could not be excluded from BBS4 (table 2.1). The complele overlap between
these two groups of unassigned families suggest thal ifboth BBS2 and BBS410<:i are
present in the population, the contribution of either locus will be relatively small. Beales
et aI. (1997) found that BBS2·linked and BBS4-linked families accounted for 17"/0 and 5%
of families. respectively. However, these loci were slightly more prevalenl in the survey
by Burford et aI. (1997): BBS2- and BBS4-linked families accounted for 24-27% and 32-
35% of families. respectively.
The finding of a large. BBS3-linked family in Newfoundland is significant in that
families linked 10 BBS3 were conspicuously absenl from surveys of families of nonhem
European extraction (Beales et aI. 1997; Bruford et aI. 1997). Moreover, this is the only
report ofa family linked to the BSSJ locus other thm that IIKd in the initial linkage study
(Sheffield et aI. 1994) and coDfirms the existence of a BB$ locus on cbromosome Jp.
Refinement of the BSSJ disease interval and a clinical description ofthis family in
comparison to the Bedouin family (Sheffield et aI. 1994) is presented in Claapcer 3.
This study finds at least three independent BBS mutations (B&$I, B&$J, and "BBSr)
segregating in the Newfoundland population. The genetic heterogeneity of BBS revealed
in the present study is consistent with the scattered geographic distribution ofBBS
families on the island (fig. 2.2) and with the findings ofother surveys. 1be results of this
study dismisses the notion that the high incidence of BBS on the island is due to a single
BBS founder. However, the finding ofmuJtiple BBS genes in the popuJation does Dot
preclude the possibility of a founder effect at one or more BBS loci. Family B9, the most
informative of the unlinked families. was used in a bomozygosity mapping strategy to
search for a DOvel BBS locus (Claapter 4). To test the hypolhesis ofa founder effect at
the BBSI locus, a linkage disequilibriwn study was pursued (CUpter 5).
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Summary
There are at least five distinct Bardet·Biedl syndrome (BBS) loci, four of which have
been mapped: II q (BBS1), 16q (8BS2), 3p (BSSJ) and 15q (BBS~. A comparative study
of the three Arab-Bedouin Icindreds used to map the BSS1, BSSJ and BBSlloci suggests
that the variability in the number and 5e\'erity of clinical manifestations, particularly the
panem of polydactyly, reflects chromosome·speeilic subtypes of BBS (Carmi ec aI.
1995). We describe a NewfoW\dJand kindred ofnorthem European descent and confirm
the initial finding ora BBS locus on chromosome 3. However, the "BBSJ phenotype,"
which includes polydactyly ofall 4 limbs and a progression to morbid obesity, was not
observed. Rather, fouroftbe five BBS patients in this family bad polydactyly restriC1ed
to their feet. 1be obesity in these patients was reversible with caloric restriction and/or
exercise. Mental retardation bas traditionally been consilierN a cardinal feature ofBBS,
however, formallQ testing reveals that the affected family members in this BBSJ·linked
family are of average intelligence. Homozygosity mapping was used to refine the BBS3
region from 11- cM to a 6-cM interVal flanked by the polymorphic markers D3S1595 and
D3S/75J.
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Introduction
Variability in the number and seve:rityofBardet.Bicdl syndrome (BBS) manifestations
is frequent and as much variation is observed among 085 patients within families as
between families (Bergsma and Brown 1975; Green et aL 1989; Canni et aL 1995; Riise
et aI. 1997). linkage studies have identified four distinct BOS loci to date. The BSSJ
locus (11q) was inferred by pooling linkage data from 17 of31 small Nonh American
families (Leppen et aI. 1994). The BSS1 (l6q; Kwitek·BIac:k et aI. 1993), BBS3 (3p;
Sheffield et aI. 1994) and BBS4 (15q; Carmi et aI. 1995) loci were mapped in unrelated.
consanguineous Arab-Bedouin families. At least a fifth locus for BBS is anticipated due
to the frnding of unlinked families (Beales et aI. 1997; Oruford et aI. 1997; Chapter 2).
The hypothesis that lbe variable clinical expression ofOBS is a result ofgeoetic
heterogeneity was proposed by Carmi et aL (1995). They compared the clinical
manifestations of patients between the tbae Arab-Bedouin families used to map the
BBS1. BSS3 and BBS4 loci. Chromosome·specific patternS in limb distribution of
postaxial polydactyly and in the extent and age.association ofobesity were observed.
Ho....-c:ver.lbese chromosome-specific subtypes were DOt supported in the clinical findings
of2 recent swveys of47 families linked to either BBSJ, BBS1 or BBS4. Similar
comparisons could not be made for families linked to BSS3 because they were not found.
(Beales et aI. 1997; Broford et aL 1997).
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We present a clinical investigation ofa BBSJ·tink:ed family ofnortbem European
descent, the first report ofa non·Bcdouin BRSJ family. We compare the phenotype ofthc
5 BBS patients in this family with that oftbc Arab-Bedouin kindr'ed used to map the
chromosome 3 Icx:us (Carmi ct at. 1995; Sheffield ct at. 1994). A homozygosity mapping
stnltcgy was used to reflDC the critical rqion of BBSJ.
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Materials aad Methods
Subjects
Family 82 is one 0£22 DDS Irindreds identified in the Newfoundland popuJation
(Greeo et aI. 1989; Harnett et aI. 1988; O'Dea et aI. 1996). The ancestors offamily 02
came from the south....'eSI of England (personal communication) and founded a small
fishing village on the tip of the south shore of Conception Bay in Newfoundland (fig. 2.2~
Chapter 2). The extended pedigrees of the spouses, persons 7 and 20, have surnames in
common with this family and are probably relaled 10 il but the connections have DOt been
found (fig. 2.1, Chapter 2). All five aduJt palients sUtpaSs the minimal requirements of
at least three major anomalies for a diagnosis ofDBS. They all have retinal dystrophy,
polydactyly, rcoaI structural aboonnalities and a history ofobe:sity. The genitalia of two
male patients were examined and showed hypoeeni1alism.
Linkage and Haplotype Analyses
DNA was extracted from the while cells of venous blood by a simple salting OUI
procedure (Miller et aI. 1988). Standard 10-J!l peR reactions contained 1.5 pmol of
primer, 200 11m dNTPs and 0.125 units ofTfl DNA polymerase (Promega, Madison, WI.
USA). The forward primer was end-labeled with y[np] -ATP by T4 polynucleotide
kinase (phannacia Biotech, Uppsala, Sweden). PeR products were run 00 standard
).,
denaturing 6% polyacrylamide-urea iels with or without fonnamide (Lin et aI. 1993) and
autoradiography was performed. Primers that flanked polymorphic microsateUite
markers located within the critical regions ofBBS/, BBS1. BSSJ and BBS4 were
purchased from Research Genetics Inc. (Hunuville, Alabama., USA) and included
D3S/776, DJS/25/. D3S/751. D3S/17/. D3S1753, D//S/198. D//S480, FGF3,
DJ/S/369, D/5S2J6, D/5S/3/. D/5S204. D/5S//4, D/5S1/l. D/6S4/9. D/6S390.
D/6S408. D/6S526. and D/6S165. Additional marlcers used to extend the haplotypes for
chromosome 3 are given in fig. 3.2.
Two-point linkage analyses were performed with the MLINK subroutine program of
FASTIINK (V3.0P), a modified version of LINKAGE (Cottingham et at. 1993; Lathrop
and Lalouel. 1984; Schllfferet aI. 1994). We modeled the BBS trait as an autosomal
recessive disorder and used a conservative estimate of penetrance [95%J. The disease·
allele frequency was set at 0.008 to correspond with an estimated prevalence of 1/17,500
previously detennined for BBS in the Newfoundland population (Green et al. 1989). All
microsatellitcs were assumed to have nine alleles of equal frequencies in the study
population. Changing the &equencyoftbe marlceror the disease alleles, or increasing the
disease penetrance had little effect on the LOD score calculations. Haplotype:s were
assigned manually and represent the least nwnber of recombinations.
Clinical/nwstigations
A protocol for clinical investigation was approved by the Human lnvestigations
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Conunittee, Faculty of Medicine, Memorial University ofNewfoundlaod, and by the
Medic:al Advisory Council of the Health Care Corporation ofSt. John's. Appropriate
infonncd consent was obtained and medic:al records were reviewed.
Pol)'dactyly, if present, provides the first diagnostic finding in newborn infants with
BBS. However, it has been our observation that brachydactyly ~ a consistent feature of
BBS and may provide a more reliable diagnostic tool. To test the significance of
brachydactyly in BBS we conducted a metacarpophalangeal panern profile (MCPP)
analysis on 14 BBS patients from 10 families (BBS group). Posterioantenor hand
radiographs were taken and the length of each oflhe 19 tubular bones of the hand were
measured according to the procedure ofPomanski et aI. (1972). Measurements were
standardized for age and sex by conversion to Z·scores (Z '" [patient measuremcnt·mean]/
S.D.) using the population means ofCaucasian individuals of nonhero European
extraction obtained by Gam et aI. (1972). A mean MCPP was ploned for the BBS group
using the average Z score for each of the 19 band bones. lbe signifteaOCC ofbaod
dysmorphogenesis for the BBS group was tested with the pattern variability index (PVl; .
en), a method that expresses the degree ofbaod dysmorphogeoesis as a single number
(Gam et aI. 1987). By using Pearsoniao correlation coefficients, we compared the
similarity between the MCPP of each patient with the BDS group.
A physical examination was performed and measurements were made ofbcight and
weight. The presence ofobesity was assessed using the body mass index (BMI) scale. A
8MI >21 was considered obese (Nelson et aI. 1994). Retinal function testing was
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performed when vision permitted. Color vision was tested with the Ishihara test, AD H·
R·R pseudoisochromatic plates and Farnsworth Panel 0-15. Visual ~eld testing with the
Goldmann perimeter. and electroretinographic (ERG) studies were performed. The
fundus was viewed with direct and indirect ophthalmoscopy and fluorescein angiography
was carried out. Psychological testing consisted of the standard Wechsler Adult
Intelligence Scale (WAIS) verbal sub-tests, and the Haptic Intelligence Scale (Stoelting
Co., Chicago. Illinois). a performance test for those with severe visual impairment. Renal
imaging was carried out by ultrasonography and intravenous pyelography. Serum and
wine tests of kidney function were conducted.
J-8
Results
LinkiJge and Haplotype AnalY5e5
TWO.poinllinkage analyses provide strong support for linkage between BBS and
chromosome 3 (BBS3) and exclude linkage to BBS1, BSS2 and BBS4 (table 3.1).
Haplotype analysis with markers spanning the BSS3 critical region show tha1 all oftbe
affected family members \\'Cfe bomozygous fOl" a portion of tile BSS3 critical region (fig.
3.1). The siblings, persons 22, 23 and 24, are homozygous for all typed marken. They
have inheriled two copies oflhe BSS) haplotype, pier 7·5·8·7·9·7-4-4 qter. Persons 14
and 15 are homoZYaous for the same alleles as their affected cousins at marker loci in the
qter portion of the BSSJ critical region.. The finding of identical, homozygous bapl()(ypCS
in affected cousins suggest that all four parents share a common anc:estty. The minimal
region of homozygosity in an affected individual was observed in person 14 and includes
the markers DJS1251, D3S1752, D3S1271 and D3S17H. If we assume that the BBS
patients in this extended family are homozygous by descent (HBD) for the BBS3 critical .
region. then these findings suggest that the BBS3 gene is located on the qter side of
marker D3S1595 (figs. 3.1 and 3.2).
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T.b'e3.1
Two-point LOD Scores Betwen lite BBS Tnil aDd Marken
in tbe Crilic::.l Repo.u oliH Fur BBS Loci
Loc,,-, Marker IF 0.00 0.01 0.10
BSS! DJIS/l98 ·7.31 4.2 -2 -1.1
BSS1 DJ6SJ90 -12.9 -5.2 ·2.6 -1.6
BSS3 DJS/751 2.84 2.77 2.5 2.15
BBS4 DJ5S104 ·7.99 4.7 ·2.5 .I.S
ClinicallnvesligolJons
Limbs
All patients in this BBSJ·linked family bad brachydactyly aDd at least a single. well·
differentiated, extra digiL The pattern was variable and IlODe ofthe BBS patients had
polydactyly ofall four limbs (table 3.2). The MCPP analysis of 14 BBS cases in 10
Newfoundland families (fig. 3.3) generated mean Z scores ranging from -0.030
(metacarpal 4) to ·3.386 (distal phalange 4). Measurements in patients were lower than
the population standards but there was some overlap with normal values. Brachydactyly
in BBS patients represents si~ficanl dysmorpbogenesis as shown by an elevated PVI
value of 1.294 (p < 0.005) (Gam el aI. 1987). All 14 patients individually showed a
significant positive correlation 10 the mean BBS pattern (p < .05; data nol shown)
including an aff~ted member of family 82 (personI4; coefficient of0.91 at p < .00(5).
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Figure J.l Family 82 with corresponding baplotypes at the BSSJ critical region. The
affected adulls have inherited two copies ofan ancestral haplotype (boxed) at the BBSJ
locus. An ''x'' denotes a recombinant haplotype.
D3SI1J4
/
/
/
/
lIcM
"
"
"
"
D38/776
D351276
DJSJ663
::;:;~IBBS3
6cM
D35/171
DJSJ7B
D3SJJ02
Figure 3.1 Rcfmc:rneot of the BSSJ disease interval by homozygosity mapping in
family B2. The loss of homozygosity at the D35/595 locus in person 14 (fig. 3.1) and a
recombination between BRS and the marker DJSI7S1 in the original Arab-Bedouin
family (fig. 1, person V-2?, Sheffield et aI. 1994) support a location for BBSJ between
markers D381595 and 0351751. a genetic distance ofapproximately 6-cM.
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Table 3.2
Limb Distribtltio. or Postaxial Polydactyly
Patient Sex
14 M
15
22 M
23 M
24
Hand Foot
L R L R
Note.- x'" extra digit; • - no extra digits
Obesity
Four of the five adult patients were obese (BMI>27) when we initially investigated this
family (Visit 1, table 3.3). Penon 14 ....oeigbed 104.3 kg with a corresponding BMI of
32.2, prior to visit I (personal communication). lbe onset of obesity was early in these
patients. For example, pcrsoo 23 was descn"bed in his medical records as a "grossly
overweight" child at age 2 yrs when he was admined to hospital to have his extra toes
removed.. Foutoftbe BBS patieots in this family have maintained or reduced their body
mass by caloric restriction, medication andIorexercise fIX the treatment of type n
diabetes. Most DOtably, person 14, diagnosed with diabetes at age 42 yrs, bas 105137 ka: .
over the last 16 years. However, his cousin (person 24), who is nee diabetic or physically
active, has gained approximately 20 kg in the seven yean since her first visit (table 3.3).
43
2
~
80+--....,.._..-+---"---,,,.----------
'1
N_1
-2
-3
-4 -41-2:t-:3~4c-t5-+-1--'2c--!3--+4-5:t-:2c--!3--+4-5-c--!2c-t3~4¥---t-5
Metacarpal Proximal Middle Distal
Fip", 3.3 Characteristic metacarpophalangeal paUem (MCPP) profiles of BBS
patients. MCPP profiles oftbe BBS group (n =14; mean Z·scores represented by solid
squattS) and patient 14 from family 82 (individual Z-scores are represented by open
squares).
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T.b~J.3
Body Mass I.des of BBS P.tinb
P=on Sex Visit Agc (yrs) Ht.(cm) W«1<g) 8MI
I' M '1 1.. 72.1 22.3
'8 1.. 67.3 20.8
1" S< I" 81.8 34.5
22 M 36 16' 79.1 29.1
44 16' 19.5 29.2
23 M 31 176 98.8 31.9
39 176 90.9 29.3
2. 22 162 78 29.1
2 29 162 98.6 31.6
Notc.· BMI- body mass index (WI [kg}/ht [m]l;
"Maintained a constant wcight for the past 12 years.
Retinol Dystrophy
A review of the medical records indicatc:s that the five affected family memben
cxperienced rapid deterioration of vision as cbildml and four oftbcm were legally blind
as adolescents. All patienlS cxamined bad advanced retinal Ikgencn.tion (table 3.4). The
retina,. as viewed in persons 22 and 24, had the fundoscopic appearance of atypical
retinitis pigmcntosa, with sparse bone spiculc pigmentation, central. and pcripbetal
atrophy, ancnuated vcssels and normal to mild optic disc palor. The retina in person 14 .
could no! be observed due 10 the presence of dense cataraelS.
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Table]."
Visual Aunsmenl or BDS Patiftall
Person Sex Age Visual Age Age
Acuity" <::>nset' Reg<" Nysf eauc ERG Fundus
14 M 51 NtP 13 Yes Yes NR NS
22 M 36 lP 10 18 No Yes NO Alyp. RP
24 F 23 LP 5 II Yes No NO AIyp.RP
~lP=No Light Perception; LP- lighl Perception only; NR- No Response;
ND= Not Done; R.P'o' Retinitis Pigrnentosa; NS- Not seen
"Onset of night blindness
"Registered blind (Visual Acuity of s 201200 or a visual field of s 20 degrees)
"Nystagmus
'Cataracts
Mental Retardation
Three of the affected family members (persons 14,22 and 24) were formally tested and
bad an average IQ (90-110) for both the perfonnaoce and verbal components oftbe test.
Person 24 has successfuJly completed public high school and ber brother, person 22, bas
obtained an undergraduate psycbology degree. Their cousin, person 14, is a retired switcb
board operator. Of the two untested BBS patients, we consider person 23 to be at least of
average intelligence as he has successfuJly completed high scbool and one year of
university courses and is employed as a customer service: supervisor with a private
company. Person IS was DOt tested because she is being trealed with lithium for bipolar
disease and it was felt that the medication would prevent an accurate assessment ofher
mental capacity. However, she did receive her grade 5 diploma before discontinuing ber
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formal education.
Urogenital System
The kidneys of persons 14. 15 and 24 were examined aoddisplayed mild to moderate
bilateral fetal lobulation with nonc or few calyceal cysts. 1be bladder and urethra were
normal. Rcsults of kidney function tcsts on all patients were normal. Senun creatininc
levcls ranged from 62 to 117 ~moles per liter (normal range: 40-130 ....moles per litcr) and
blood urea nitrogen (BUN) levels ranged from 3.5- 6.3 mmoles per liter (normal range:
3.5·7 mmoles per liter). Urine tests were either negative or showed tracc amounts of
blood or protein. The genitalia oftwo male patients were examined and revealed
hypogenitalism.
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Discussion
CliniClJllm"C!SliglJlioru
The variation in the number and severity of c1inicai manifestations ofBBS is weU
documented (Bergsma and Brown, 1975; Carmi et a1. 1995; Grccnetal. 1989; O'[)eaet
al. 1996; Riisc et aI. 1997). Carmi et aI. (1995) JWCSCIlted phenotypic comparisons among
three multiplex Arab-Bedouin families linked to 8BS1. 8BS3 and 8BS4 and suggested
that the clinical variability reflC(:ts the expression of different DBS geQCS. The
confirmation and delineation oflocus-specific BDS phenotypes could be of prognostic
value and may expedite the search for family-specific (private) mutations.
Limbs
Limb abnormalities provide the fust significant diagnostic finding in ocwbom infants
ofkno",'D D8S families. However, postaxial polydactyly, often cited as a major
manifestation ofDBS, is not a universalfiDding (Ammann. 1970) and is observed in only
58% of patients in the Newfoundland population (Green et aI. 1989). Str\ICtW3.l
anomalies such as brachydactyly and syndactyly arc present in all BDS patients from
Newfoundland (Green et aI. 1989; O'Dea ct al. 1996). To evaluate the significance of
brachydactyly in 88S, we examined the bands of patients by MCPP analysis and found a
reduction in the mean tubular bone length, representing a significant deviation from the
DOnnal pattern. The ifOuP BDS profile was highly correlated with that of individual
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patients. This suggests that the MCPP pattern for BBS is quite homogeneous. Since
BSS is a progressive disease with multiple affects, early diagnosis of newborn infants
with MCPP analysis may be useful when patients present without polydactyly.
The extent of limb involvement of postaxial polydactyly has varied from a single extra
digit to an extra digit on both hands and both feet ofBBS patients (Green et aI. 1989;
Klein and Ammann 1969). In the Arab-Bedouin kindred linked to BBS3, Carmi et aI.
(1995) observed that II of 12 affected family members bad polydactyly of all four limbs.
They suggested that polydactyly of all four limbs is a distinctive component of the BBS3-
specific phenotype. However, none of the five patients in the Newfoundland family
linked to BBS; had polydactyly of all four limbs and four of them bad involvement oftbe
feet only. No distinctive family pattern of polydactyly was observed in this study or has
previously been observed among families in the Newfoundland population (Green et aI.
1989) or in 44 other families linked to BBS}, BBS2 or BBS4 (Rudling et aI. 1996). Carmi
et aI. (1995) noted a more random distribution of polydactyly among the BBS2- and
BBS4-linked Arab-Bedouin kindreds. Our observations suggest that the pattern of
polydactyly is also variable among BBS; patients.
Retinal Dysrrophy
Retinal dystrophy is probably the most constant and invariable finding in BBS. The
visual changes occur in childhood and manifest either as a loss in central visual acuity
and/or decreased night and peripheral vision. The retina appears to be thin and atrophic
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with a less striking scattmng ofblmelt pigment thaD that of typical retinitis pigmentosa
(Ammann. 1970; BeU 1958; Scbachat and Maumenee 1982). By the.second or third
decade of life. the BSS patient experiences a severe loss of cenual and peripbera1 vision
(Green et aI. 1989; Jacobson et at 1990; Futon et at 1993). All 80S patients examined
from Newfoundland have a severe retinopathy and 50'% are legally blind by age 18 yrs
(O'Dea et aI. 1996). The visual defecl was severe in this BBSJ family as all patients were
legaUy blind by age 18 yrs. The retinal appearance was thatofan atypical fonn of
retinitis pigmentosa, a familiar pattern amongst Newfoundland BDS patients (Green et. at.
1989).
Mental Relardation
Mental retardation has uaditionally been considered a cardinal feature ofBBS. based
on the delayed psychomolor development of affected children.. lbis approach fails to
take into account the diminishing edocatiooal opportunities, due to the progressive nature
of the visual defect associated with retinal dystrophy. in these patients. We reported
earlier !hat when appropriate verbal and performance IQ 1eSlS fOf'the visually impaired
were used, only 41% ofNewfouodland BBS patients were considered mentally retarded
(Green el al. 1989). A study by Riise et al. (1997) reports that the social performance of
adults with BSS is higher than the IQ scores of childhood would predict and most
patients function within the normal range of intelligence. FormallQ testing and
social/academic perfonnance indicale thallll least four of the five BOS patients in this
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family are of average intelligence. Therefore, the prognosis of mental retardation for
BBS patients shouJd be reconsidered and efforts made to meet their special educational
needs.
Obesity
The degree of obesity in BBS is variable within families but tends to occur early in
childhood and increases with age (Bell 1958; Ammann 1970; Green et aI. 1989).
Observations of the Arab-Bedouin family suggest that BBS3 patients progress toward
morbid obesity (Carmi et aI. 1995). All patients in this BBS3 family are currently or have
been obese as are most BBS patients in the Newfoundland popuJation (O'Dea et a1.
1996). Observations ofthese adult patients over the cowse of this study demonstrated
that the obesity is reversible. In an eight year period, only one patient experienced weight
gain. The maintenance or loss of weight can be attributed to efforts to control blood
glucose levels due to type II diabetes, diagnosed in three of the patients in this study and
32% of BBS patients in Newfoundland. Four unrelated BBS patients in our clinic also
have had successful weight reduction with caloric restriction (O'Dea et al. 1996). The
responsiveness of the obesity associated with BBS to caloric restriction and aerobic
activity is encouraging and warrants further evaluation.
Urogenital System
In the Newfoundland popuJation, some abnormality of renal structure, function or both·
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is universal among BBS patients and was described in previous reports (Hamen et al.
1988; Green et al. 1989: O'Dea et at. 1996). The renal structural changes typically
include the persistence of felallobulation and calyceal cysts as observed in the three
affected relatives who were examined in this BBS3 kindred. 1be major cause of
morbidity and mortality among BBS patients is renal failure (Churcltill el aI. 1981; Green
et al. 1989: O'Dea et aI. 1996). However, the relationship, ifany, ofthe renal structural
abnonnalities to renal failure in these patients is unknown.
Linkage and Haplotype Analyses
The original linkage ofBBS to chromosome 3 was established in an Arab-Bedouin
kindred (Sheffield et at. 1994). However, population·based surveys of 47 BBS families
(of predominantly northern European descent) have failed to yield a single BBS)·linked
family (Beales et aL 1997; Bruford et aI. 1997). We previously surveyed 17 BBS families
identified in the Newfoundland population (Chapter 2) and delennined that family B2 is
linked to BBS], continuing the original finding oCa BBS locus on chromosome 3
(Sheffield et al. 1994).
Homozygosity mapping of recessive diseases in consanguineous pedigrees can
potentially refine the disease interval to a few million base pairs of DNA, a region small
enough to attempt positional cloning oCthe putative gene (Lander and BOlstein, 1987).
Affected relatives will be HBD for markers closely linked to the disease gene because
they inherit two copies of a singJe ancestral haplotype that includes the disease locus.
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Haplotype analysis in family B2 reveals that only affected family members show
homozygosity, presumably HBD, for maIkers in the 8BSJ critical region. Three affected
siblings, persons 22, 23 and 24. inherited two copies of the ancestral haplotype pter 7-5-8-
7-9-7-4-4 qter. Their cousins, persons 14 andIS, also inherited two copies of the
ancestral haplotype but one copy has been shortened through recombination (retaining the
qter portion) (fig. 3.1). Since all parents of affected offspring originate from the same
small, isolated fishing village on the Avalon Peninsula, it is probable that they share a
common ancestry. A single, disease-associated haplotype segregating in both affected
sibships in this extended family suggests the individuals affected with BBS are
homozygous for a single recent founder mutation. The ancestral chromosome 3
haplotype does not appear to be prevalent in the Newfoundland population as it was not
observed in any members of the other 16 families that we have genotyped.
Refinement a/the BBS3 Disease lntervaf
The initial linkage orBBS 10 chromosome region 3p13-12 localized the putative BBSJ
gene to a II-cM region between markersDJSl254 and DJSf302(Sheffieid et al. 1994).
However. a close examination oftbe Bedouin pedigree presented in the original report
depicts a recombination belween D3SJ 753 and the disease locus (person V-27, fig. I.
Sheffield et al. 1994), indicating that the BSS3 gene is located telomeric of the marker
D3SJ 753 (fig. 3.2). The results of homozygosity mapping in family B2 suggests that
BBS3 is located centromeric of the marker D3SJ595 (figs. 3.1 and 3.2). On the basis of .
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our observations ofthe Bedouin pedigree linked to BBS3 (Sheffield et aI. 1994) and the
results from this study, we predict that the BSS3 gene is located in the 6-<:M region
between D3S/595 and D3S/753.
A mutation in anyone ofat least five distinct BBS genes results in a similar, multi-
organ pheno~with characteristic limb abnormalities. This suggests that the BBS
genes encode subunits of a multimeric protein or are members of a common biocbemical
pathway involved in embryogenesis. 1be 6-<:M genetic interval containing the BBS3 gene
(fig. 3.2), corresponds to the J, K and L contigs in the centromeric region of chromosome
3 (Chromosome J Framework Map, The San Antonio Genome Center). This region is
too big for a positional cloning approach to identifY the BBS3 gene. A search of the
National Center for Biological information (NCBI) database shows that 82 cDNAs,
including 17 genes, map to the region. Many sequences have appropriate temporal and
spacial expression to be candidate genes for BBS3. For instance, three genes, CBLB
(Cas-Br-M (murine) ectropic retroviral transforming sequence b), an inhibitor of
epithelial growth factor (EGF)-induced cell growth with a distinct role in EGF signaling,
TOMM70A (translocase ofouter mitochoodrial membrane 70 (yeast) homolog A), a
thyroid hormone-regulated gene with a role in brain development, and DOC 1 (down-
regulated in colon cancer I), a myosin heavy chain homolog, are all expressed in the
embryo and in a wide array of adult tissues, including those perturbed in BBS, such as
brain, kidney and testis. Other BBS3-linked families may need to be identified in order to
refine the disease interval and identifY the BBS3 gene.
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To the Editor:
Batdct-Biedl syndrome (BBS) is a rare aUIOSOmaI. recessive disorder with major"
clinical manifestatiODll of retinal dystrophy, obesity, dysmorpbic extremities,
hypogenitalism. and renal struc1wal and functional abnonnalities. It is distinguished
from Laurence-Moon. syndrome (OMIM 2458(0), Biemond syndrome U (OMIM
210350), and Alstrom syndrome (OMIM 2038(0) by the absence of paraplegia, iris
coloboma, and perceptive deafness, respectively. Four genetic loci for BBS have been
mapped to distinct chromosomes, but the finding, in three recent population surveys, of
several unlinked families with BBS provides convincing evidence for at least a fifth BBS
locus (Beales et al. 1997; Bruford et aJ. 1997; Cb.pler 2).
BBS is a relatively rare disease, with an estimated world prevalence of 1/125,000-
160,000 (Klein and Ammann 1969; Beales et all997). However, two genetically
isolated and distinct popuJations have been identified that provide a resource ofJUEe
inbred families with BBS. One in 13,500 individuals has BBS in the Bedouin·Arab tribes
of the Negev region oflsrael. where the custom ofconsangu.incous maniages is still
practiced by > 50% of the population and where two-thirds of these marriages arc
between first cousins (Farag and Teebi 1989; Sheffield et al. 1998). Halfa world away,
on the island ofNcwfoundland, the prevalence of BBS is 1117,500 (Green C1 al. 1989).
Matings between distant cousins in the Newfoundland popuJation are frequent because of
three historical factors: the geographical isolation of coastal fishing villages, the low rate
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of immigration to these communities, and the religious restrictions on male selection
between the ProteslaDl English and Catholic Irisb settlers (Bear et aI. 1988). Three ohbe
four BBS loci -BSS1 (K.witelr.:·BIacl:: et al. 1993), BBSJ (Sheffield et aI. 1994), and BBS4
(Carmi et aI. 1995) -were identified by homozygosity mapping in individual Bedouin
families. We bave used a similar methodology 10 map the fifth genetic: locus for 88S to •
chromosome 2q31 in an inbred Newfoundland family of Ewopean anc:estry.
A recently compleled population-based survey of 17 88S families &om Newfoundland
has identified six families in which the four known 8BS loci were unambiguously
excluded (Chapler 2). Family 89, the largest of these kindteds, has five affected
members who are the products of three consanguineous unions intelTelated through two
founding couples (fig. 2.1, Chapler 1). The methods used in the clinical assessment of
these: patients have been described elsewhere (Green et al., 1989). The five oBS patients
with BoS surpass the minimal criteria ofthtee majordinical manifestations for a BoS
diagnosis, because: of the presence of obesity, brachydactylyand/or syndactyly, retinal
dystrophy, and male hypogenitalism. in the absence of paralysis, iris coloboma, or
deafness (table 4.1). This pedigree met the requirements for the localization of BBS5 by
homozygosity mapping (lander and Botstei.n 1987; Carmi et aI. 1995). We anticipated
thaI the affected individuals would be homozygous by descent for an ancestral haplotype
inherited &om one oftbe four pedigree fowtders.
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TabJc4.1
Clinical ManifcstatioDS of BBS5 ia a NcwfoUDd1aDd Kbldred
8M!' Polydactyly! Visual Retinal Small
Patient (Sex/Age) Othe~ Acuity" Appearanced Penis
21 (M!3! years) 31.7 NonelYes LP Advanced RP y"
22 (Mf15 ycan;) 34.6 NonelYes NLP Retinal No.
degeneration examined
24 (F /29 years) 49.4 NoneIYes NLP Atypical RP Not
applicable
28 (M /25 yean;) 40.4 NonelYes CF RP y"
29(F/21 yean;) 42.8 NonelYes 201300 Macular Not
dystrophy applicable .
'BMI=body mass index (wt [kgJlht (mF). A value >27 is considered to indicate obesity
(Nelson et aI. 1994).
l>Qther=brachydactyly and/or syndactyly
<CF=count fingers; lP=light perception only; NLP=no light perception
dRP=Retinitis pigmenlosa
A genomewide scan of pooled DNA samples was perfonncd 'With microsatellite
markers, the vast majority (89%) consisting oftri· and tetranuclcotide repeats
(Cooperative Human Linkage Consortium human screening set, Weber version 8;
Research Genetics), as described elsewhere (Sheffield et al. 1994). Two control pools of
DNA from 4 living pareOts and II unaffected siblings, as well as a test pool of ONA from
the 4 surviving patients, were amplified. Of the first 322 markers successfully amplified,
6 showed a reduction in the number ofalleles (allele shift) in the test pool, compared to
the control pools. Subsequent genotyping of these markers on the extended family
proved that they were not linked to BBS, resulting in a false-positive rate of 1.9%.
However. the 323«1 marker. D2S/353, gave a 4:1 allele sltift, from the control pools to the
test pool. Genotyping of D2S/353 on the pedigree showed it to be exclusively
homozygous in patients with BBS. Two-point analysis showed significant linkage
between BBS and D1S/353. with no recombination (maximum LOO score [z.......] 5.675;
recombination fraction [9] 0). Genotyping of markers flanlcing D2S/353 confinned
linkage to 2q31 (table 4.2) and showed an ancestral haplotype that is homozygous by
descent in all affected relatives (fig. 4.1).
Table 4.2
Two-Pnint LOD ~orn Between the BBS Tnit and 2q31 Marken
Marker .~ 0.000 0.010 0.050 0.100 0.200 0.300 z... at.
D2S442 -3.080 -2.205 -1.224 -0.699 --0.211 -0.042 0.009 0.43~
D2S1399 -0.416 0.982 1.321 1.174 0.722 1.345 0.122
D1S/353 5.675 5.556 5.075 4.463 3.214 1.970 5.675 0.000
D2SI776 4.691 4.578 4.121 3.543 2.377 1.275 4.691 0.000
D2S1391 1.617 2.558 2.600 2.066 1.298 2.631 0.078
Note.-A disease model of autosomal recessive inheritance, 100"/. penetrance, and a gene
frequency of0.008 was invoked.
&Listed according to physical order (pter-qter) on chromosome 2q31.
bCalculated by MLINK and ILINK from the FASTLINK package (version 4.0P).
The initial assignment of the BBS phenotype in close proximity to the HOXD gene
cluster on chromosome 2q3 t suggested these nine homeobox genes of the
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Figure. 4.1 CosegregatioD oCBBS and an ancestral. haplotype (boxed) on chromosome
2q31 in kindred 89. Double marriage lines indicate consanguineous unions. HapJotypes
were constructed manually and represent the minimal number ofn:combinations (:1:). "The
DNA sample from person 24 14-'as extracted from a paraffin sample aDd often fails to
amplify, but this person appears to be nonrecombinant for bolh parental chromosomes.
The minimal region of homozygosity in relatives with BBS includes the markers pter-
DZSl14, D151330. D1SJ776 and D1SJJS-qter.
...
Drosophila antennapedia class and other closely located genes (EVX2 and DLXI/DLX2)
that are involved in patterning of the embryo are candidate genes for BBSS. Recent
findings that duplication of the HOXDl3 gene causes synpolydactyly(Akarsu et aI. 1996)
focused our attention on it as the most promising gene candidate. given that syndactyly
and/or polydactyly are congenital manifestations ofDBS. However. refined mapping of
two key recombinant ancestral chromosomes in patients 1S and 12 placed BBSS within
thel3-<:M interval D2SIS6-D2S1218 (fig. 4.1). several centimorgans upstream from the
HOXD13 gene that is positioned at the proximal end of the HOXD gene cluster (fig. 4.2)
(Spurr et aI. t 996). Refined mapping of the recombinant ancestral chromosome excludes
all genes within the HOXD gene cluster as candidate genes for BBSS.
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Fip" 4.2 Critical region ofme novel BBS5 locus on chromosome 2q31. Markers
used to refine the position ofBBS5 are identified in terms oftbeir "0" numbers. The
marker order and distances v..ere based on the Marshfield Chromosome 2 (sex.-averaged)
linkage map (Center for Medical Genetics. Marshfield Medical Research Foundation) and
the Chromosome 2 Workshop Consensus Map, )996 (Genome Database). The HOXD-
gene cluster lies telomeric to the BBSS critical region.
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Summary
Bardet-Biedl syndrome (BBS) is a 1'lVe, aulosomal recessive disorder, major pbenorypic:
findings include dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism,
and renal aoomaIies. In the majority of northern European BBS families ""ith DDS, the
syndrome is linked to a 2tkM region 00 cbromosome Ilq13. However, the finding, so
far, offivedistmct BBS loci (BBSI, llq; BBS2. l6qj BBSJ, Jp; BBS4, 15q; BBS5,2q)
has hampered. the positional cloning oftbese genes. We used linkage disequilibrium
(LD) mapping in an isolated founder population in Newfoundland to significantly n:duce
the BBSI critical region. Extensive baplotyping in several unrelated BBS families of
English descent revealed that the affected members were homozygous for overlapping
portions ofa rare, disease-associated aocestraI. haplotype 00 chromosome IlqlJ. The to
data suggest that the BBSI gene lies in a I_Mb, scquence-ready region on chromosome
llq13. which should enable its tdentification.
'·2
IDtroductioD
Baniet·Biedl syndrome (BRS; OMIM 209900) is a rare, aUlosomal recessive disorder
in which the combinatioo ofdysmorphic extremities, retinal dystrophy, obesity, male
hypogenitalism and reoal anomalies may be associated, 10 varying degrees, with mental
retardation andlordiabeles mellitus (Green etal. 1989; O'Dea et aI. 1996). Of the five
genetic subtypes, BBSI appears 10 be the most conunon locus in affecled individuals of
northern European descent: as many as 50% of linked pedigrees are assigned 10 BBSI
(Realesetal. 1997; BNford etal. 1997; Woods et aI. 1999). DBSI was initially mapped
[0 chromosome IIql3 by combining the posilive LOD scores achieved in 17 of 31 North
American kindreds as a result ofa genome scan (Leppert et aI. 1994). The other BBS
loci, BBS2 (16q; Kwitek.·Black.et aI. 1993), DBS3 (3p; Sheffield etal. 1994), BBS4 (I5q;
Canni el aI. 1995) and BBS5 (2q; Young et aI. 1999), were located by homozygosity
mapping in extended inbred kindreds. In the original study of Leppert el aI. (1994), the
putative BBSI gene was lightly linked 10 two loci on chromosome llq13: the gene for
human muscle glycogen phosphorylase (PYGM) and the anonymous DNA marker
DI IS913 (AFMl64zf12), and was localized loa 26-<:M in[erval between DIlS1298 and
!NT2 (FGF3). A more precise genetic and physical location ofBBSI is required if the
BBSI gene is to be positionally cloned.
Refined mapping of disease genes has recently been accomplished by linkage
disequilibrium (lD) mapping in founder populations (reviewed by Jorde 1995 and by
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Xiong and Guo, 1997). When a disease mutation is first introduced into a population. it
resides on a single disease: haplotype (OH) of linked markers. As a result of meiotic
recombination, the length of this DH decreases as a function of genetic distance so that.
with successive generations, only the original marker alleles in the vicinity of the disease
locus cosegregate on disease chromosomes. Although fine mapping ofdisease genes was
established initially in old populations like the Finnish (Hastbacka et aI. 1992), recent
success in fine mapping has been accomplished in relatively young populations (Labuda
et aI. 1996; Groenewald et al. 1998). The island population of Newfoundland, considered
a genetic isolate because of the nature of its founding and subsequent isolation. is
enriched for BBS, with 10 times the incidence in other white populations of northern
European ancestry (Green et aI. 1989; O'Dea et aI. 1996). A single founder effect bas
been reported in two recent studies of families from the island with either hereditary non-
polyposis colorectal cancer (HNPCC) or multiple endocrine neoplasia type I (MENl)
(Q(ufemi et aI. 1998; Froggan et aI. 1999). In the preseDt study we show that. in five
unrelated families from Newfoundland, the family members affected with BBS are
homozygous for an ancestral DH, and we use recent and historical recombinations to the
ancestral DH 10 map the BBSI gene within a I-Mb region on chrornosome Ilql3.
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Materials and Methods
Subjects
In a recent population survey, 17 BBS families of English ancestry were haplotyped at
the 8BS}, BBS2. BBS3. and BBS41oci. Of these families. three (88, BID. and B19) were
assigned to BBS} and three (B7, 812. and B15) could DOt be excluded from this locus
because they yielded positive LOD scores and haplotypes consistent with linkage to BBS}
(table 2.1, Cbapter 2). Of these six families, parental consanguinity was documented in
family B8 and suspected in families BID. 812. Bl5. and B19 on the basis of progenitors
with the same surname originating from the same community. Extensive genotyping with
markers mapping to the BBSf critical region was performed in the six families.
representing 8 BBS patients and 44 first·and second-degree relatives. Informed consent
had been obtained previously. and the clinical presentations of the adult patients have
been described elsewhere (Green et aI. 1989; O'Dea et aI. 1996).
Genotyping
DNA was extract~d from the lymphocytes of venous blood by a simple salting out
procedure (Milleretal. 1988). Fifty to 100 ngoftemplate DNA in standard 10·IJL
reactions containing 1.5 pmol of primer. 200 IJrn dNTPs. 0.125 units ofTfl DNA
polymerase. and a trace amount ofy(l2p] end·labeled forward primer was amplified by
temperature cycling in a Perkin Ebner 9600 thennocycler. Products were run on 6%..8%
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polyacrylamide sequencing gels with formamidc (Lin et at. 1993) and were subjected to
autoradiography. The markers 01181298, 0118956, D/ /8480,011$4205,0/ /SI883,
D/ /84945, PYGM, 0/ /84946, D/ /S4940, 01 /S4938, D/18449, D/ /84941, D118913, .
and FGF3 were typed on key family members. Family 87 was excluded from the study,
because several samples failed to amplify.
Family Studies
Haplotypes were constructed, for each family, to give the minimum number of
recombinations. DHs were identified from alleles that were transmined from both
unaffected parents to affected offspring. Pairwise linkage analyses between BBS and six
markers spanning the BBSI critical region were performed under an autosomal recessive'
model with a penetrance of 0.95 and a disease-allele frequency of .004. The disease-
allele frequency for BRS was calculated from the Newfoundland population estimate of
1/17,500 (Green et aL 1989), adjusted to reflect an estimated 50"/0 contribution ofthe
BBSI locus to the overall population frequency. AU markers were assumed to have nine
alleles of equal frequency in the population. LOD scores were calculated by the MLINK
subroutine program of FASTLINK (V3.0P) (Lathrop and Lalouel 1984; Cottingham et
al. 1993; SdUifferetal. 1994).
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Populotion Stl/dies
The marker-allele frequencies in disease and normal (nontransmitted) chromosomes of
the 10 obligate BBS carriers (parents) wen:: compared. Nonnal alleles from each parent
were used as popuJation controls. to avoid the possibility of inadvertently including BBSI
disease alleles from random carriers in the popuJation. Allelic association was tested by
means of Fisher's exact test. with one-sided probability. 'The DRs were compared
between families in search of (i) common BBSI haplotype5 that wouJd indicate that the
parents of two or more families were distantly related and (ii) a common ancesttal DH.
5-'
Results
Preliminary Evidence ofa Founder Effect Among Families with BBSI
Five aCthe six families in this study live along the south and southwest coasts of
Newfoundland (fig. 5.1). Although a common ancestor was nol identified in ancestral
lineages. genetic evidence suggests that the families are interrelated. The affected
individuals in family 810 are apparently heterozygous for a copy aCme DH identified in
family B8 and a portion of tile DH transmitted by the father of family 87 (table 5.1). It
was noted that these three families originate from c1osely·linked communities on the
TableS.1
DMs on Cbromosome IlqJ3 Segregating in Six BDS Familiet
B7 B8 BID BI2 BI5 BI9
Marker
DIISI298
DIIS956
DIIS480
DIISI883
DIIS913
FGF3
Note.-Haplotypes are arranged with the paternal haplotype (P) on the left and the maternal
haplotype (m) on the right. For markers DJ 15913 and FGF3, the phase of the paternal
haplotype in B12 is assumed.
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BBSI
Figure 5.1 Geographical location of six BaS families with evidence oflinkage to the
BBSI locus. The families genotyped in the present study are indicated by family number.
The location of8BS1., BBSJ~, and BBS5·linked families (as determined in Ch.pten 1
and 4) is shown.
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southwest coast of the island (fig. 5.1). The data also suggest that the father ofa south
coast family (B12) shares a recent common ancestor with both parents of family Bl5, the
only family not residing on the south coast of the island. Therefore, on the basis of shared
DRs and geographical location. preliminary evidence suggested the preseoce ofa fowtder
effect among BBSi cases in the Newfoundland population.
Evidence ofLinkage to BBSI
In a previous study, three families (88, BIO, and B19) were assigned [0 BBSI (table
2.1, Chapter 2). Family BIO consists ofa large sibship in which two affected individuals
share a unique genotype on chromosome Ilq13. compared to their nine unaffected sibs
(fig. 5.2). A maximum LOD score of 1.662 at recombination fraction (9) 0 was obtained
with fully infonnative markers that mapped telomeric 10 DllSJ883. Family BIO was
previously excluded from linkage with BBS2, BBSJ, BBS4 (Chapter 2), and BBS5 (M..O.
Woods, unpublished data) on the basis ofestablished exclusion criteria. For a locus to be
excluded, one or both ofthe following conditions had to be met: (i) affected individual(s)
inherited the same genotype as one or more unaffected sibs. and (ii) two or more affected
individuals inherited different genotypes. Family B8 is a consanguineous family in which
a single affected offspring was homozygous by descent (HBD) for the entire BBSI locus
(fig. 5.2). A maximum LOD score of 1.405 (9=0) was obtained with fully infonnative
markers (e.g.• DIISI883). Homozygosity (in the affected member only) was not
observed at other BBS loci: BBS2 and BSS3 loci were excluded. Family B19
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Figure S.2 Core pedigrees of three families linked to BBSI (D8, 810 and 819) and
three unassigned families (87, B12 and 815) haplotypcd for six polymorphic markers
spanning the 26-cM BBSI interval on chromosome llq13. Blackened symbols indicate
individuals with diagnoses of BoS. Boxed haplotypes (solid and dashed lines) indicate
DHs. Double marriage Ji~ depict consanguineous unions. either documented (solid
line) or suspected (dashed line). "R" indicates that the DH is recombinant.
consists ofa large sibship with one affected individual. The affected offspring was
homozygous (presumably HBD) for all markers typed within the BBSI interval, whereas .
seven unaffected sibs were either beterozygous or homozygous for a normal haplotype.
Homozygosity was DOt observed at other 8RS loci, and the BSSJ locus could be excluded
(Chapter 2).
In three families (87,812, and 815), 8RS could not be excluded from. or confidently
assigned to, the BSSI locus (Chapter 2). Family 815 coosists ofa large sibship \\;th one
affected and eight unaffected sibs available for geDOtyping. Homozygosity in the affected
individual was observed only at the BSSI locus, and the BBS3 locus could be excluded.
Family 87 has two affected individuals who share a unique g<notype on chromosome
Ilq13, compared to their four unaffected sibs (fig. 5.2). A maximum LOD score of 1.074
(9=0) was obtained with fuHy informative markers, and BBS in this family was excluded
from linkage to BSS3, BBS4 and BBS5 (M..O. Woods., unpublished data). Family 8 12 is
relatively uninformative for linkage but was excluded from BSS3 because the only
affected individual (patient 14) inherited the same genotype as his unaffected sister. He is
homozygous for the BSSI marker DI18913, but the phase of the patemal chromosomes
cannot be determined for the D11S913- FGFJ interval because ofan apparent
recombination in one of the offspring.
The pairwise LOD scores calculated for the six families at six markers covering the 26-
cM BBSI critical region were summed. Four of six martcers examined reached statistical
significance when the families were considered together (LOD score> 3; table 5.2). The
Table 3.2
Sum oftbe Pairwise LOD Scores.t Cllromoso.e lIq13 ia Sis F••ilia with BSS
LOD Seon: .t 8=<
Marker 0.000 0.010 0.050 0.100 0.200 0.300 0.400
DllS1298 2.227 2.263 2.169 1.856 1.124 0.052 0.142
DllS956 3.419 3.439 3.275 2.867 1.910 0.972 0.279
0118480 2.809 2.819 2.623 2.202 1.288 0.559 0.137
01181881 3.657 3.663 3.430 2.952 1.868 0.894 0241
0118911 3.019 2.923 2.546 2.093 1.264 0.587 0.151
FGFJ 3.777 3.662 3.203 2.644 1.599 0.739 0.190
finding of conunon DHs among BBSI-assigned families (88 and BIO), between BBS1-
assigned and unassigned families (87 and 810), and among unassigned families with
evidence of linkage to BBSI (812 and 815) (table 5.1) corroborates the linkage and
haplotype data that these are, in fact, all BBSI families. Because the exact relationships .
among the pedigrees are unknown, the sumntal}' LOD scores given in table 5.2 are
presumed to be underestimated. Obligate recombinations involving the DHs were
detected in several families and used 10 refine the BBSI interval. In family B 10, an
unaffected individual, person 14, inherited a non-recombinant DH from his father and a
recombinant DH from his mother. The presence of two DHs for the centromeric portion
of the BBSI critical region (Dl181298 to DIISl883) in an unaffected individual suggests
thai marker Dl1S1881 is the new centromeric boundary for BBSI (fig. 5.2). Similarly, a
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recombinant paternal haplotype inherited by an unaffected sib in family 88 (person 12)
suggests lhat BBS1 is located centromeric to FGF3. Intrafamilial recombinations on DHs
reduce the BB81 interval from a 26-<:M regiontoa 15-<:M interval betweenDJ181883
and FGF3 (fig. 5.3).
LD ond Detection ofa Founder Hap/otype
Extensive genotyping at the BBS/ locus focused on markers within the new BBS/
interval (fig. 5.3). The distribution ofalleJes at 14 polymorphic loci in disease and
nonnal chromosomes is shown in table 5.3. Significant LO between specific marker-
alleles on OHs was observed across the families. Strong associations were observed
between alleles at five consecutive marker loci: D/ /54205,0/15/883,0/184945,
PYGMand 0/ /84946. Comparison of allele frequencies between disease and normal
chromosomes showed that three ofthese associations were statistically significant. Allele
10 at marker D//S/883 was present on 70% (7/10) ofOHs but only 20"10 (2110) of
normal chromosomes (P < .05). Similarly, allele 8 at the PYGM locus was present on
100% of the OHs and 50"/0 of Donnal chromosomes (P < .05) and allele 5 at marker
D/ /84946 was present on 100% of the disease chromosomes and 30"10 ofDonnal
chromosomes (P < .01). Although allele 4 at marker D/ /84205 and allele 9 at marker
D/ /S4945 were present on 90% and 100% ofdisease chromosomes, respectively, these
associations were not significant, because both alleles are common in the general
population; they are present on 70'% of the nonnal chromosomes (table 5.3).
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BSS1 Intrafamilial Linkage
Interval Recombination Disequilibrium
llq13
Figure 5.3 Refinement of the BBS} disease interval by recombination and LD
mapping in Newfoundland families. The markers and their relative positions were
selected from the map of the MEN} region on llql3 (Manickam et al. 1997; Sixth
International sew II Workshop, 1998).
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A single ancestral OH was readily identified in the vic:inity ofmarkez' loci with
strong allelic: associations. AU disease c:bromosomes segregating in BBSI families
c:ontained the ·9-8·5- subbaplotype at DIIS4945, PYGM, and 011S4946,
respccti\·el)·. In c:onttasl, the ·9-8-5· suhhaplotype was only found on a single normal
haplotype (family B8). This suggest that, although rare, the ·9-8-5· subbaplotype is
not exclusive to BBSI-carrying c:hromosomes in the Newfoundland population. It
was noted that the existenc:e of a single BSSI founder haplotype: in these families was
not evident on tbe basis of a six-marker haplotype, due: to large gaps between markers
(table 5.1).
The longer - 4-10-9·8-5- haplotype (encompassing tbe -9-8·5- subbaplotype and the
centromeric markers 01IS·/105 and DIISI883) was identified on 60".1. of the OHs
but none of the normal chromosomes. This longer haplOtype may represent a larger
portion oftbe ancestral OH. In this case, OHs discordant for allelelO at 01 /SI883
(families Bl2 and B19) may have resulted. from either (i) historical recombinations to
the ancestral OH between 01 IS1883 and DIIS4945 that were not informative at
Dl IS4205, a notably wllnformative marker in the population, or (ii) de novo
mutations at the more polymorphic DIISI883 locus. In any case. the evidence
suggests that the ·9-8-5· subhaplotype represents either the remnants ofa founder
BBSI chromosome imponed from England or the background haplotype that
sustained a BBSI mUlation de novo in the genniine ofa single Englisb senter.
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Lrxation ofBBS I
LD mapping suppons a position for the BBSI gene within a l-eM region between
markers DIIS1883 and DIIS4940 surrounding lhe PYGMlocus. The DlISl883
boWldary is also supported on the basis ofintrafamilial m:ombination (fig. 5.3). This
l-eM genetic interval represents a physical distance of- I-Mb (Manickam et aI.
1997) within a region oftbe genome that is gene rich and, fortuitously, sequence
ready as a result of physical mapping eff"ons to clone the Best vitelliform macular
dystrophy (VMD-2) and multiple endocrine neoplasia (MENI) genes that map 10 this
region (Cooper et at. 1997; Guru et aI. 1997; Manickam et al. 1997).
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Discussioa
]be island ofNewfoundland is a sparsely populated region ofCanada in which
50% of the population of 560.000 reside in small coastal communities. The
colonization ofttle island occW'Ted primarily by a nanuaJ increase from northern
European settlers of predominantly English and Irish extraction who arrived before
1835. Most founders originated from the West Country of England and from
southeast Ireland (Mannion 1917). Mating segregation between lri.sh CatholiC5 and
English Protestants, low immigration, and geographical isolation ofcommunities
have resulted in genetic isolation of the population. In a review of the historical
development of genetic isolation in three Newfoundland outpOltS, Bear e1 aI. (1988)
observed that only 1'Y...8% ofbrecding parents were immigrants to the area and 60%
of births had been to parents originating from the same small community.
The scattered distribution of BBS families and the recent identification of at least
three distinct genetic BSS subtypes in Newfoundland (Chapter 2) is not consistent
with the expectation of a single cluster of families with a recessive disease in a young
founder population. However, we noted that five of the six families with evidence of
linkage to BSS} reside on the south and southwesl coasts of the island, a region that
was settled predominantly by the spread of settlers by sea in an east-t~wcstdirection
(Mannion 1911). The gellOtyping data also suggest that these families have complex
relationships with each other in that large regions (up to 26-cM) on disease-associated
baplotypes were shared among kindreds. In the absence of mutation analysis, the
identification of a single founder effect would require that all patients were
homozygous for specific alleles at marker loci tightly-linked to the BBSI gene. We
have shown that all BBSI patients identified in the Newfoundland population are
homozygous for a relatively rare haplotype spanning a I.-eM region centered around
the prOM gene on chromosome Ilql3. The relatively high incidence ofBBS and the
scattered distribution ofaffected families in the Newfoundland population are
attributable to a combination of locus heterogeneity and at least one founder effect.
The power ofLO mapping is weU illustrated from this study: a total of six affected
individuals in five families were used to fine map the BBSI gene to within I-Mb by
this method. Even families not informative for linkage (e.g., B12) provided valuable
information on historical recombinations. In contrast, two recent studies reporting on
a total of47 families with BBS failed to identitY informative recombinations at the
BBSI locus (Beales et aI. 1997; Bruford et a1. 1997). The localization of BBSI within
a I-Mb interval between DIISI883 and 01/S4940 is smaIl enough to promote the
positional cloning of the BBSI gene.
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Bardet-Biedl syndrome is a clinically and genetically heterogeneous disorder in which
mutations al anyone of at least five genes cause a pleiotropic phenotype including
congenital dystrophic extremities, infantile onset obesity, progressive retinal
degeneration, renal aboormalities, and male hypogonadism. Despite the lapse of seven
years since the first BDS locus was mapped (Kwitek-Black et al. 1993), DOne of the BDS
genes have been cloned. The wide spectrum of clinical manifestations ofBBS makes it
difficult to prejudge the pUlative BBS gene product(s), precluding a fuoctiooal candidate
gene approach to the identification oftbe BBS genes. More significantly, the refinement
of the genetic map to allow positional cloning at one or more oftbe BBS loci has been
impeded by, (0 a limited number ofBBS cases (ii) locus heterogeneity, and (iii) the
Iwnping together ofBBS with other, possibly non-allelic syndromes.
Tbit itlbe Ont report or. pop.lalio.-bucd iavntiplio. of 8RS i•• weD-
denaed pop.lalioa. The premise of this thesis was thai a latie collection of well-
described BSS families, from a founder population like Newfoundland. would provide: a
unique opportunity to study the genetics ofBBS and contribute to the cloning ofBBS
genes.
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Genetic Heterogeneity ofBBS in the Newfoundland Population
Seventeen of22 Newfoundland families were tested for linkage at eacb of1be:
previously mapped BBS loci (BBSI-BBS4). In total, eight families (31%) have been
unambiguously assigned to a specific BBS locus, seven oftbem (32%) to previously
mapped loci and one family to a oovellocus (BBSS) (fig. 6.1). A total of 14 BBS families
(63%) identified in the Newfoundland population remain unassigned (five families
unlinked at BBSI, BBS1, BBS3 and B884, four uninformative families and five families
that were unavailable for study) (fig. 6.1).
Six families, representing 27% of the 22 BBS families, were assigned 10 the BBSI
locus (fig. 6.2), three the result of linkage and haplotype analysis (Chapter 2) and three
on the basis of linkage disequilibrium (Chapter 5). Like other repons of families of
nonhero European extraction, BBSI is the: largesllinkage category so far in the
population. Geograpttic and genetic evidence suggest that the affecled individuals in
these six BBSI families are homozygous for a founder mutation. implicating a single
mutation at the BBSllocus in all BBSI cases in the population (Chapter 5).
The genetic survey revealed two unpredicted findings. The first was the relatively
large nwnber offamilies that were not linked to any of the previously mapped BBS loci
(Chapter 2). The second surprise was the finding of a BBS3- linked family (Chapter 3),
the second only DSS3 family reported in the literature and a unique finding among
patients of northern European extraction. One of the unlinked kindreds, family B9, was
used to successfully locate a novel BBS locus (BBS5) on chromosome 2q31 (C.apter 4).
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Figure 6.1 Relative proportion of assigned and unassigned BBS families in the
Newfoundland population.
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Figure 6.2 Swnmary of linkage assignments in Newfoundland families with BBS
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The existence ofeither BBS2, BBS4. or other novel BBS genes in the population could
not be ruled out because of the many unassigned families (6g. 6.1). I_ colIClusio_, these
findings suant a miDimum or tltne BBS Ielles (1JIISl, IJIISJ, and BlISS) are
present in the Newfoundland population.
Benefit ofthis Study to Individuals and Families Affected by BBS
Eight Newfoundland BDS families were assigned with confidence to specific BBS loci
(fig. 6.2). Although the underlying genes have not been identified. disease·associated
haplotypes could be used for carrier testing in these families. This is particularly
imponant for family members of reproductive age who choose a partner from within their
community or from a neighboring community. especially for family members originating.
from the south and south west coasts ofNewfoundland where the BBSI carrier rate must
be relatively high due to founder effect (fig. 6.3). In identified BBS families. haplotype
analysis could also be used to conium the diagnosis in young children, a prerequisite for
appropriate early interventions and patient management. For example. the provision of
special education with low-vision aids. and dietary intervention to prevent or treat obesity
and diabetes mellitus. are imponant early interventions that can maximize the potential of
an person with BBS to develop into a bealthy and independent adult.
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BBSI
Figure 6.3 Geographicalloc3tion of BBSI-, 8BS3-, and BBS5-linked families and
BSS families that remain unassigned in Newfoundland. The 5 families not available for
genotyping in this study are denoted by an "x". lbe "88SI founder" arrow indicates the"
historical settlement panern that occurred along the south coast.
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PhenotypiC Subtypes ofBBS
"The genetic bct:erogeneity of 8BS in association with variable phenotypic expI"CSSion
begs the question of locus·specific pbeootypes. The specific pbcnotypic manifestations
of tile BBSJ locus as proposed by Canni eta). (1995) Yo"U"e DOl supported (Cuptn- 3).
However, me finding, in this study, of six fami.lies with an ancestral haplotype (O_pkr
5) presents a~ opportunity to explore the efTects ofgenetic background and
environment 00 the expressivity ofa single mutation, in this case at the BBS} locus. In
general, the number ofBBS families that can be assigned to a specific BBS locus, per
research group. are small. Therefore, an international collaborative efTon. to establish
diagnostic criteria and standardize clinical assessments may be the only means 10 truly
evaluate locus-specific expression of BBS.
Future studies on Newfoundland BBSfamilies
"The conclusion of this thesis in no way completes the investigation into the genetics of
DDS in Newfoundland. The occurreoce ofone rare (BBSJ) and at least one DOvel (B855)
DDS gene in the Newfoundland population is intriguing. The availability of 14
unassigned families, some of them quite informath-e {e.g., family BI3}, provides ample
resources for fu~ studies, Oflhe 14 unassigned families, five families have oever been
examined (untyped). Blood samples need to be collected on these BDS patients and their
families 50 genetic investigations can begin (fig. 6.4, step 4). Although it is prudent to
genotype all five BDS loci in each family, priority should be given to BSS} markers
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Figure 6.4 Outline of future studies involving Newfowtdland BOS families and the
stcp--wise approach to positional cloning.
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because two oflhese families originate from the soulh west coast (fig. 6.3).
Another priority is that the five unlinked (aod informative) families be tested for
linkage at the novel BBSJ locus (fig.. 6.4. step 5). The linkage studies of BBSS should be
augmented with a searcb for linkage disequilibrium using the disease--associated alleles
identified in family B9 as reference alleles. 1be finding offouoder effect among BBSS
families in uninformative f3lTlilies would not only provide locus assignments for the
families but may also help refine the BSS5 disease inlerval.
The I"llre finding ora BBSJ·linked family (82) originating from the Conception Bay
area is interesting in that several unassigned families reside in neighboring communities.
This includes two of the lhree uninformative families (8 II. B14 and B16) that could not
be excluded from linkage at the BBS) locus and one of the untyped kindreds (fig. 6.3).
These families need to be genotyped for disease-associated alleles identified in family B2
to investigate the possibility of a BSSJ founder effecL Refine mapping bas been
completed on the six families linked to BBSI. These families are available for mutation .
testing of candidate genes within the BSSI disease interval (fig. 6.4, step 10).
Towards the Pos;tionol Clotf;"gofBBS Genes
As the major BBS locus., it is anticipated that BSSI will account for the majority of
BBS cases. In this regard, the most significant outcome of my thesis work is the
refinement oCthe BSSI disease interval to I-Mh. small enough 10 make it amenable 10
positional cloning. The major organ systems affected in BBS arc the limbs., gonads,
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kidneys, and eyes. Because of the congenital nature ofseveral pbeootypic features of
BBS (limb defect, hypogenitalism and calyceaJ blunting), the BBS genes must normally
be expressed during the first trimester when tissues and organs are being modeled.
Although functional candidate genes for BBS are difficult to imagine, the search for
candidate genes within the reflned 8BSI interval shouJd focus on sequences that are
expressed in the tissues involved in the BBS phenotype.
Refinement of the BBSI disease interval from a 26-cM to I~M region (DIISI881-
DIIS4940) was accomplished by LD mapping (ellapter 5). Support for the location of
BBSI within the DI ISI883-DI IS4940 interval was recently established by a study of
recombinations in multiple BBS families that suggests that BBSI is located between
markers DIIS4205 and DIIS913 (Katsanis et a1.1999), a region that totally encompasses
the refined disease interval detennined in this thesis (Cbapter S, fig 5.3). BBSI is tightly
linked to PYGM, the locus for muscle glycogen phosphorylase. This region on
chromosome 11q 13 is gene rich and well characterized with polymorphic markers (Graff
eta!. 1997; Manickamet aL 1997), physical maps (Cooperel a1. 1997; Guruet a1. 1997b;
Smith et a!. 1997 ), and transcript maps (Guru et al. 1997a; Sawicki et a!. 1997; Zhu et al.
1998) developed in a flurry of activity to clone the genes for mutilple endocrine neoplasia
(MENI) (Chandrasekharnppa et a1. 1997) and Best macuJar dyslrOphy (BMD) (petrukhin.
etal.1998).
Although no recombination has been observed between the BBSI phenotype and
PYGM, recombinants were identified with more proximal and distal markers. The
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minimal linkage interval for the BSSI gene: is a I·Mb region (Dl /SI88J·D/ /54940).
Genes excluded from the disease inter\'al are too numerous to list but include genes
previously suggested as candidates for BSS1, such as lite human homolog (OVOl/) c.fthe
Drosophila avo gene that results in hypogenitalism., reduced ability to reproduce, and
kidney aboormalities in knockout mice (Dai et aL 1998).
1be positional candidate genes for BSSI include lWelve knoWD genes identified
between markers DllS/88J and 01154940: YRF, FKJJPZ. PNG. PlepJ, Neurexin,
PYG,\1, Nu, ZFM/. GC-Kinase, Mu, Kappa and H-PAST(Guruetal. 1991a). A search
through the Unigene database at the National Center for Biologicallnformation (NCBI;
www.ncbi.nlm.nih.gov)showsthatmanyofthesegenesareexpressedinawidevarietyof
tissues. Four other genes reportedly map to this interval: a novel human CDC2S·like
(HCDC25l) gene and a dystrophia myotonica protein kinase-like (DMPKL) gene map to
the S' end (OIISIMJ·PYGM) oflhe disease interval; a novel and ubiquitously expressed
gene, GCKNG (genninaI center lcinase-oeighboring gene), maps telomeric to PYGM
(Kedra et aI. 1991); a homolog oflhe human p70S61cinase gene (p7lh6 k) (relative map
position unknoWD), is universa.lly expressed, including within adipose ceUs and retina
(Zhu et aI. 1998).
To distinguish the BSS/ gene from all other positional candidates in this gene-densc
region of the human genome is a formidable task. The only report ofmulation testing
with any of these candidate genes (H.PAST) has failed to find mutations in BBS patients
(Haider et aI. 1999). The timely identification of BSSI will require both informative
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families and substantial sequencing efforts. To ..eel these nfluinDleats, .ad as.
result of DIy tbesis work, our group .t MeDlorial Univenlty has e.barked o. an
internation.1 collaboration witb Ibe sequendnl «aler al Baylor ColJece of Mediciae
in Houston, Teus.lo identify Ibe BaSI geae.
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